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1. SCIENTIFIC BACKGROUND 
1.1 Microbiota and probiotic bacteria 
1.1.1 Microbiota 
The human gut is colonized with about 1014 microorganism including bacteria, yeast 
and archea. The bacterial density varied within the gastrointestinal tract (GI tract). 
There is an increased augmentation of bacteria from the stomach to the distal colon. 
So the number of microbial cells is 10 time higher than the total number of all cells of 
the human body. About 500 to 1000 species inhabit the gastrointestinal tract. This 
microbes form a unique complex and dynamic ecosystem, also term as mircobiota 
(Artis 2008; Manson et al. 2008). Bacteria can have diverse effects to the host. Harmful 
bacteria such as Clostridium ssp., Veillonella ssp., Proteus ssp. and the family of 
Enterobacteriaceae induce pathogenicity or transform food components into harmful 
substances like ammonia, amines or hydrogen sulfide. Bacteria of the intermediate 
group including Bacteroides ssp., Eubacterium ssp. and anaerobic Streptococci ssp. have 
no pathogenic effects under normal condition. Bifidobacterium ssp. and Lactobacillus 
ssp. are beneficial bacteria suppressing harmful bacteria and have beneficial 
physiological effects to the host. The normal gut composition is termed microbiota 
(Gill and Prasad 2008). 
 
1.1.1.1 Development of microbiota 
The gut of a newborn is sterile and becomes colonized with different microorganism 
after birth. It needs 7 to 10 days until a baby develops a heterogeneous bacterial flora. 
Newborns feeding full-term with breast milk have a limited bacterial composition 
which is predominated of Bifidobacteria and also includes Lactobacilli, Escherichia coli 
and Enterococci. The microbiota of formula-fed babies are more complexer and includes 
species of Bacteroides, Clostridia, Bifidobacteria, Lactobacilli, gram-positive cocci and 
coliforme bacteria (Givens Bell 2007; Manson et al. 2008). During the first year of life 
the microbiota is characterized through a low diversity and high unstable bacterial 
composition. At the age of two years there are no more difference between the 
bacterial composition of breast-fed or formula-fed children (Bik 2009). The initial 
colonization is finished around three years of age. During this phase the human body 
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becomes imprinted to these microorganisms and tolerates them. This microbiological 
imprinting influence the immunological imprinting and thus the immune response 
(Artis 2008). The diversity and stabilization increases with age. But there a high 
differences between each segment of the GI tract (Bik 2009). The density of bacterial 
colonization increases from the stomach with 103 – 104 cfu/g to the colon with 1010 to 
1011 cfu/g. Also the composition alters within the GI tract (Gill and Prasad 2008). 
Following factors affect the establishment of bacteria within the GI tract:  the rapid 
turnover of intestinal epithelium and their overlaying mucosa as well as mucin 
expression and the exposure to peristaltic activity, available nutrients, kind of 
transient bacteria, pH and secretion of gastric, pancreatic and bile acid. The 
composition of the adult microbiota is also influenced by kind of diet and the 
genetically background. The 500 to 1000 species in the gut are members of just 11 
bacterial divisions. Eight of them are represented rare within the gut. About 93% of 
bacterial species are members of the division Cytophaga-Flavobacterium-Bacteroides, 
Firmicutes and Cytaphaga-Flavobacter-Bacteroides. The small intestine contains the 
genera Bacteroides, Clostridia, Streptococci, Enterococci and γ-Proteobacteria. The bacterial 
composition of colon includes species of Bacteroides, Clostridia, Prevotella, 
Poryphyromonas, Eubacteria, Ruminococci, Streptococci, Bifidobacteria, Enterobacteria, 
Lactobacilli, Peptrostreptococcus and Fusobacteria (Manson et al. 2008). 
 
1.1.1.2 Function of microbiota 
The microbiota is a stable and well organized ecosystem playing an essential role for 
the human health. Some bacteria are capable to digest and synthesize nutrients which 
the human organism cannot digest or synthesize itself. For instance, Firmicutes sp. 
ferments human indigestible polysaccharide to short chain fatty acids such as butyrate 
using the host organism as energy source. The synthesis of vitamin K and vitamin 
B12 through Bacteroides and Eubacterium are essential for the human (Bik 2009). 
Furthermore, the commensal bacteria play a crucial role in the development of 
epithelium and regulation of immune response because they are able to avoid the 
colonization of potential pathogens through exclusion by competition for the same 
nutrients and attachment site. Microbiota also promotes angiogenesis within the 
epithelial cells and secretes anti-microbial peptide itself. As example for the 
immunomodulation function, germ-free mice’s shown hypoplastic Peyer’s patches, an 
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increased level of plasma cells, abnormal spleens and lymph nodes as well as 
underdeveloped intestinal villus capillaries. All this deficiencies can restore by 
colonization of one single Bacteroides species (Artis 2008; Bik 2009). Moreover, 
commensal bacteria are involved in the differentiation, recruitment and maintenance 
of mucosal-associated invariant T cells. The development of chronic inflammation is 
associated with changes in bacterial composition (Artis 2008). 
 
1.1.2 Probiotic bacteria 
FAO and WHO define probiotic bacteria as “live microorganisms which when 
administered in adequate amounts confer a health benefit on the host” (FAO and 
WHO 2001). 
The declared health benefits of probiotic bacteria include: 
• Improvement of intestinal microbial balance 
• Stabilization of gut mucosal barrier  
• Characteristics of an immune adjuvant  
• Prevention of infection and food allergies including abatement of intestinal 
bowel diseases symptoms and enhanced digestion of lactose in intolerant 
hosts 
• Beneficial properties against respiratory tract infections  
• Reduce the duration and frequency of  viral diarrhea  
• Reduction of serum cholesterol 
• Anti-cancerogenic activity (Galdeano et al. 2007; Gill and Prasad 2008) 
 
Conventional strains of lactic acid bacteria such as Lactobacilli, Bifidobacteria, 
Streptococci and Lactococci are used as probiotic bacteria. These bacteria are usual 
components of fermented milk products, cheese, fruit juice and sausages and used as 
single or mixed cultures of lived organisms for food preparation. To become a 
classification as a probiotic bacterium, the strain should have following properties: 
• High cell viability even under conditions of low pH  
• Be resistance against proteolytic enzymes, antimicrobial peptide, sIgA and 
bile acid 
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• Ability to persist in the intestinal tract even if the bacteria strain is not able 
to colonize within the gut 
• Attachment to intestinal epithelial cells and interact or send signals to 
initiate an immune response (Galdeano et al. 2007). 
 
To achieve a measurable effect a quantity of 108 to 109 cfu/day are required and the 
bacteria have to remain within the GI tract at 48- 74 hours. It could observe that a 
viability of Lactobacillus delbruecki ssp. bulgaris was not needed to initiate a positive 
immune response. But if live bacteria or non-viable bacteria are supplemented affect 
the time of resistance in the gut. Non-viable bacteria are cleared faster (Galdeano et al. 
2007). 
 
1.1.2.1 Probiotic bacteria affect the composition of microbiota 
The treatment with Bifidobacterium longum led to a lower level of lecithinase-negative 
Clostridia in feces. Bifidobacterium bifidum B12 induced a higher number of resistant 
Bifidobacteria and a lower level of Clostridia in feces. After a supplementation for 7 
days with Lactobacillus acidophilus LA2 an increased amount of resistant Lactobacilli 
and Bifiodbacteria was observed in feces samples. The combination of L. acidophilus and 
B. bifidum resulted in an increased number of resistant Bifidobacteria and a decreased 
level of coliforme species in feces after a consumption of 10 days. A relative long-term 
study with Lactobacillus rhamnosus DR20 has shown a change in Lactobacilli and 
Enterococci species in the feces of the most consumers. Bifidobacterium animalis subsp. 
lactis B19 was offered in 4 different concentrations from 108 to 1011 and it was found 
an increasing level of B. lactis B19 with higher dose. But the general bacterial 
composition was not altered. An elderly population was supplemented with B. lactis 
HN019 in 3 different concentrations (15 x 109, 109 and 6.5 x 107). Even at lowest dose 
an augmentation of resistant Bifidobacteria, a reduction of Nitrobacteria and a higher 
amount of Lactobacilli was observed. These few examples indicate that probiotic 
bacteria affect the composition of microbiota in a strain-dependent manner (Gill and 
Prasad 2008). 
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1.2 Immunoregulation in the gut  
1.2.1 Introduction 
The gut is not just the organ of digestion and absorption of nutrients. With a surface 
area of about 200 m² is the gastrointestinal tract (GI tract) the largest human surface 
where interactions with the exogenous environment take place. And is thus the most 
important site of entry for many pathogens. Mechanisms to protect the human body 
against invasion of pathogenic microorganism include physical barrier, anti-microbial 
components like anti-microbial peptides, mucin and trefoil peptides; specialized 
immune response as well as indigenous microbiota which prevent the establishment of 
pathogenic organisms through competitive exclusion. There are two kinds of immune 
responses: inflammatory or tolerance. The second task of the GI tract is the 
maintenance of the immune homeostasis through protecting the body from potentially 
pathogenic organisms and inducing tolerance against innocuous food, commensal 
microbes and self-antigens. Approximately 80% of the total human antibody 
production occurs in the gut and makes it to the most important physical and 
functional barrier of the immune system. A dysregulation of gut homeostasis lead to 
several inflammatory reactions such as bowel diseases. To cope with this task there 
are various mechanisms at the tissue, cellular and membrane level (Mason et al. 2008; 
Brandtzaeg 2009). 
 
1.2.2 Morphology of GI-tract 
To achieve a surface of about 200 m² an invagination/ projection at several levels is 
needed. The mucosa is formed into villi and crypt (figure 1). Villi are covered with 
intestinal epithelial cells which have additional microvilli. The tip of villus is bordered 
by  filamentous brush border glycocalyx to optimize the uptake of nutrients and limits 
the invasion of bacteria or large molecules (Mason et al. 2008). 
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1.2.2.1 Mucus layer 
 The surface of epithelium is coated by a 
mucus layer which has visco-elastic 
properties and consists of intestinal 
glycoconjugates, mucin and glycocalyx. 
Mucin and glycoconjugates are 
important for the physical barrier 
function.  Glycoconjugates are also 
required for the adhesion of pathogenic 
bacteria and toxins. There are also 
express a high amounts of sIgA on 
mucosal surface to bind to pathogens in 
the lumen and prevent their adhesion to 
epithelial cells. Thus the mucus layer 
protects the human organism by preventing invasion of microorganism to the 
underlying mucosa and may  play a role in favoring colonization of the GI tract 
(Akarid et al. 2002; Velàzquez et al. 2005). 
 
1.2.2.2 Intestinal Epithelial cells 
The intestinal epithelial cells (IECs), an array of mucosal lymphocytes and the 
mucosa-associated lymphoid tissue (MALT), are located between lumen (Dahan et al. 
2009). The IECs contain enterocytes, colonocytes, globlet cells, enteroendocrine cells 
and paneth cells. Together with the mucus layer IECs compose the intestinal 
epithelium forming the physical barrier against pathogens and control the access to 
the mucosal compartments. Intestinal epithelial cells play a crucial role in the immune 
response in the gut because they are capable to secret immunostimulating signal 
molecules like cytokine, chemokine and eicosanoide (Mason et al. 2008). For instance, 
during a bacterial invasion IECs elicit a cascade of chemokines including IL-8, 
epithelial neutrophil-activating protein 78, monocyte chemotactic protein, 
macrophage inflammator protein 3α, and cytokines like IL-18, IL-7, IL-15, 
granulocyte-macrophage colony-stimulating factor, IL-6 and TGF-β. Thus IECs are 
also termed as non-professional antigen-presenting cells (APCs) (Dahan et al. 2009). 
 
Figure 1: Overview of intestinal immune system (Lunds 
Universitet 2008) 
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1.2.2.3 Follicle-associated epithelium 
The follicle-associated epithelium (FAE) occurs segmental throughout the intestine 
(figure 1). Its development is regulated by underlying lymphoid cells (Velàzquez et al. 
2005). FAE is a monolayer with a lower number of distinct brush border, less amounts 
of digestive enzymes and a higher level of immune cells (Mason et al. 2008). The 
function of FAE is the collection of antigens from luminal site. Therefore it is a part of 
Peyer’s Patches or isolated lymphoid follicles (Velàzquez et al. 2005). Micro fold-cells 
(M-cells) are characteristic for FAE. They facilitate the transportation of antigens to 
the specialized antigen-presenting cells (APCs) within the subepithelial dome (SED) 
of Peyer’s patches (Mason et al. 2008). 
 
1.2.2.4 GALT 
The tissue complex involving in the immune response within the GI tract is termed as 
gut-associated lymphoid tissue (GALT). The GALT is a subset of mucosa-associated 
lymphoid tissue (MALT). It is composed of intraepithelial lymphocytes, Peyer’s 
patches (PP), lamina propria and appendix at the inductive sites of the gut. Soluble 
proteins and microbes are able to cross the epithelial barrier under the control of M-
cells and are transmitted to Payer’s patches. PP have large B cell follicles with 
intervention T cells in the subepithelial dome (SED) where antigens from the lumen 
are collected. Lamina propria is the effector site of GALT including professional 
immune cells such as macrophages, neutrophils, lymphocytes which produce a large 
number of pro- or anti-inflammatory cytokines and chemokines (Mason et al. 2008). 
The GALT is the largest lymphoid organ in the human body because it contains 70% 
of the total number of immune cells (Erickson and Hubbard 2009). The function of 
GALT is to limits and controls the immune response. Therefore it must be capable to 
distinguish harmless antigens presenting in food or commensal bacteria, from 
pathogenic microbes. That is difficult because pathogenic and symbiotic/ commensal 
microorganisms express the same molecular pattern. In general harmless microbes do 
not elicit an inflammatory immune response. Thus the recognition of microbial 
pattern is not crucial to indicate an immune response. Additionally signal of “danger” 
like molecules released from damaged or apoptotic cells as well as changes in 
membrane composition are necessary (Mason et al. 2008). 
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The mesenteric lymph nodes (MLNs) are the largest lymph nodes in the body 
mediating immune interaction between GALT and periphery. GALT and MLN are 
the primary tissue involving in the gut immunology (Mason et al. 2008). 
 
1.2.3 Components of the Gut Immune Response 
1.2.3.1 Introduction 
The human immune system includes local immune tissues termed as mucosa-
associated lymphoid tissue (MALT) and the systemic immune system taking place in 
the blood, spleen, liver and bone narrow. A subset of the MALT is the gut-associated 
lymphoid tissue (GALT). About 80% of total immune cells are contained within the 
GALT. There are two types of immune systems: the innate (non-specific) and the 
adaptive (specific) immune response. Both could be humeral or cellular mediated. The 
innate immune system includes cells like macrophages, neutrophils and NK-cells to 
kill the pathogenic organism. The adaptive system required the aid of antigen-
presenting cells (APCs) or cytokines which are released in response to an infection or 
rather in response to pathogens. The actors of adaptive immune response are T and B 
lymphocytes. B lymphocytes induce a humoral response through specific antibody 
production. T lymphocytes lead to a cell-mediated response. Naïve T CD4+ cells 
differentiate into helper T cells (TH) after stimulation by antigen receptor of their 
surface. TH1 activates macrophages and TH2 induces a differentiation of B cells. 
Activated T CD8 cells kill pathogenic organism directly. B and T cells which are 
antigen-activated within the GALT migrate through the lymphatic system to the 
blood stream (Akarid et al. 2002). 
 
1.2.3.2 Pattern recognition receptors 
Intestinal epithelial cells are bordered with pattern recognition receptors (PRRs). 
PRRs like lectin, adhesins, family of nucleotide-binding oligomerization domain 
(NOD) receptors and Toll-like receptors (TLRs) are a part of the innate immune 
system. They activate an adaptive immune response. Their task is the recognition of 
the presence of infection as well as pathogenic organisms and the releasing of 
signaling molecules to elicit an adaptive response. 
The most important PRR are Toll-like receptors. Intestinal epithelial cells express 
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TLRs variable, depend on type of cells and depend on cell compartment as well as the 
region within the GI tract. The major function is the protection of human body 
against a dysregulation of inflammation in the presence of commensal bacteria within 
epithelial cells (Dahan et al. 2009). There are different subset of TLRs with specific 
ligands binding to a various microbial and host components, also known as pathogen-
associated molecular pattern (PAMP) (Mason et al. 2008). Characteristics of TLR 
ligands are 1) expressed only by microbes, but not by host cells, 2) invariant between 
microorganisms of a given class, 3) essential for the survival of microbes and 4) 
recognized by TLRs. Nowadays 13 TLR subset are known. For instance, TLR4 are 
stimulated by lipopolysaccharide (LPS) and endotoxin; TLR1, TLR2 and TLR6 
binding specific to bacterial lipoproteins as well as zymosan; bacterial flagellins bind 
to TLR 5. TLR 9 is specialized to unmethylated CpG present in DNA (Erickson and 
Hubbard 2009). The dilemma is the discrimination between pathogenic microbes and 
beneficial organisms which is complicated by the fact that pathogenic as well as 
commensal species have the same PAMPs. Thus several other mechanisms like 
recognition of virulence factors or negative regulations at various stages of TLR 
signaling cascade, have to be also involved in the discrimination (Mason et al. 2008). 
When a ligand binds to a TLR it induces a signal transduction pathway often via 
NFκB leading to a pro-inflammation response (Dahan et al. 2009). A stimulation of 
TLR can results in an enhanced uptake of microorganisms by phagocytosis cells or 
killing of microbes by secretion of reactive oxygen and nitrogen intermediates. A 
recruitment of leukocytes to the site of infection are elicit because TLR induces the 
expression of E-selection as well as intracellular adhesions molecule-1 on cell surface. 
A chronic stimulation of TLR leads to IgA production, but this response does not 
result in an acute inflammation. The increased IgA secretion leads to a broadly 
increased protection against pathogenic bacteria at inductive site (Erickson and 
Hubbard 2009). 
Dendritic cells (DC) have also various PRRs on their surface. Thus they have the 
ability to detect groups of microbes with PAMP by binding to PRRs on DCs surface 
which induces a downstream activation or inhibition of inflammatory pathways 
(Mason et al. 2008). 
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1.2.3.3 M-cells 
Micro fold cells (M-cells) have short irregular microvilli (Erickson and Hubbard 2009) 
and facilitate the transport of macromolecules from the intestinal epithelial cells to the 
Peyer’s patches (PP) where are professional antigen-presenting cells (APCs) like 
macrophages, dendritic cells as well as B and T cells. The transport of 
macromolecules is a very important step of mucosal immune response and thus a 
crucial point of pathophysiology. The transfer of information could be occurs 
indirectly through the expression of chemokines or directly by the transfer and 
present of APCs to lymphocytes. In response to pro-inflammatory signals M-cells up-
regulate the production of MHC class I and MHC class II molecules (Dahan et al. 
2009).  
 
1.2.3.4 Peyer’s patches 
Peyer’s patches (PP) are an aggregation of lymphoid follicles which are located along 
the antimesenteric side of the small intestinal mucosa and are a part of mucosa-
associated lymphoid tissue. The epithelium associated site is composed of enterocytes 
and is also interspersed with M-cells. PP respons to antigens passing the intestinal 
epithelial barrier. They are subdivided into follicular and parafollicular area as well as 
follicle-associated epithelium. The germinal center of PP contains proliferating B 
lymphocytes, follicular dendritic cells (DCs) and macrophages. The dome area above 
the follicle comprises B cells, DCs, macrophages and T cells. The activation of B 
lymphocytes leads to the production of IgA and IgM (Erickson and Hubbard 2009). 
Lymphocytes activating in PP are transmitted to mesenteric lymph nodes and from 
there return to lamina propria and other secretory tissues through thoratic dut and 
blood vascular system (Erickson and Hubbard 2009).  
 
1.2.3.5 Dendritic cells 
Dendritic cells (DCs) are professional antigen-presenting cells (APCs) presenting 
antigens to T cells in the lymphoid tissue and NK cells. Subsets of specialized DCs 
was found on the inductive as well as effector site within GI mucosa. They are the 
major gatekeeper to interact with the innate and adaptive immune response within the 
GI tract. All subsets of DCs express the signal molecules CD11c and major 
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histocompatibility complex (MHC) class II. But they are different in the release of 
CD8a and CD11b. Myeloid DCs CD11c+ CD11b- are located in the subepithelial dome 
of Peyer’s patches (PP) and plasmacytoid CDs are located in the interfollicular region 
of PP.  An inflammatory or tolerated immune response is influenced by released 
signaling molecules from DCs and T cells. For instance, CD11+ subsets in PP 
expressing low level of Interleukin (IL) -12 and a high amount of IL-10 playing a 
crucial role in tolerated response. In contrast CD8+ CD11b- has an increased 
expression of IL-12 and a reduced expression of IL-10 leading to an inflammatory 
response. Further the location of DCs is crucial of induced immune response. As an 
example, the activation of DCs of PP by the ligand RANK leads to an induction of 
polarized T cells to produce IL-10, an anti-inflammatory cytokine. But spleenic DCs 
would induce an IL-12 production resulting in a pro-inflammatory response. That 
indicates DCs proximity to intestinal epithelial cells (IEC) induce tolerance when 
there is a steady-state, absence of inflammatory signals and/ or infection in IECs 
(Mason et al. 2008). DCs also stimulate CD4+ T cells inducing the development of 
immunoglobulin (Ig)A- committed B cells in lymphoid follicle. These B cells migrate 
from PP to mesenteric lymph nodes (MLN) via lymphatic channels. Further they 
migrate back to intestinal lamina propria (LP) through thoratic duct and blood 
vascular system. Arrived at the effector site B cells and plasmablasts differentiate into 
IgA producing plasma cells under the influence of IL-5 and IL-6 which are secreted by 
TH2 cells. Several forms of IgA bind to polymeric Ig-receptors leading to secreatory 
IgA (sIgA). SIgA is not associates with an inflammatory response. They are resistant 
against proteolysis and mediate immune exclusion of foreign antigens by preventing 
binding to IECs as well as penetration of microorganisms (Erickson and Hubbard 
2009). 
 
1.2.3.6 T cells 
T cells are a part of the adaptive immune system which is activated by antigen-
presenting cells. For instance, helper T cells (TH) are activated after a presentation of 
antigens in context with major histocompatibility complex (MHC). The subset TH1 is 
involved in an inflammatory response and stimulation of cytotoxines in T cells. 
Whereas TH2 producs cytokines which activate specific B cells. And TH3 has a 
suppressive affect to effetor cells by releasing the inhibitor cytokine transforming 
SCIENTIFIC BACKGROUND 23 
 
growth factorβ (TGFβ) (Erickson and Hubbard 2009). Regulatory T cells (TR), also 
known as suppressor T cells, are involved in the regulation of tolerance. In the GALT 
there are antigen-nonspecific and antigen-specific TRs. Natural TRs express CD25, 
CTLA-4, GITR and Foxp3. Subsets of CD4+ CD25+ are important for the 
maintenance of homeostasis within the human body by recognition of self-antigen and 
preventing an inflammatory response to chronic stimulation. Adaptive TRs subsets 
like TH3 and TR1 cells, both are CD4+ T cells, are required for intestinal immunity. 
TH3 is activated after an induction of oral tolerance and are capable to influence the 
expression of IgA. TR1 cells produce IL- 10 leading to an anti-inflammatory response 
(Mason et al. 2008). 
 
1.2.3.7 B cells and antibody production 
80% of all plasma B cells are located in the GI tract. B cells produce specific 
antibodies. For the production a stimulation of helper T cells are partly needed. The 
response to the commensal intestinal microbiota is in general independ of T cells 
induction. A theory of this observation is it requires a more broadly spectrum of IgA 
to protect the body against microbiota, whereas a production of IgA to neutralize 
bacterial toxins requires a high specific affinity which needs the induction by T cells 
(Mason et al. 2008). Precursor B cells of Peyer’s patches migrate to the gut mucosa 
where they ensconce into their follicular site. After a successfully antigen-dependent 
activation they move away to mesenteric lymph nodes and from there to lamina 
propria where they mature to antibody-producing plasma cells (Velàzquez et al. 2005). 
The major immunoglobulin (Ig) isotype on the mucosal surface is secretory IgA 
(sIgA) having anti-inflammatory properties and protects the mucosal surface from 
pathogenic invasion. SIgA is also required to maintain the gut homeostasis and 
tolerance. An IgA deficiency is associated with an increased risk of gastrointestinal 
infection in human (Mason et al. 2008). About 3 g of dimeric sIgA are translocated to 
the gut every day. For that reason the gut is the largest antibody producing organ in 
the human organism (Brandtzaeg 2009). But IgA also plays a necessary role in the 
regulation of gut microbiota. For instance, in human an IgA deficiency is associated 
with an higher amount of Escherichia coli strains with pro-inflammatory properties 
(Mason et al. 2008). 
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1.2.3.8 Phagocytes 
Phagocytes are non-specific immune cells recognizing pathogens and destroy or 
eliminate them by phagocytosis. Phagocytosis is a term of enzymatic digestion of 
pathogenic organism within host cells. Furthermore, phagocytes secret cytokines to 
warn other cells in the organism as well as attract other immune cells to the site of 
invasion. They also secrete anti-microbial peptides and reactive oxygen species (ROS) 
to kill microorganisms outside the own cell. Phagocytes are necessary for the 
discrimination of “self” or “non-self” cells (Danilova 2006). 
 
1.2.3.9 Macrophages 
Macrophages play a crucial role as antigen-presenting cells which release factors 
attacking other immune cells and pro-inflammatory mediators like IL-1, IL-6 and 
TNFα after ungulfing and phagocytosis of pathogens. When macrophages ingest 
apoptotic cells they express anti-inflammatory factors like TGF and IL-10 (Danilova 
2006). 
 
1.2.3.10 NK cells 
Nature killer cells (NK cells) have the task to screen cells for the presence of specific 
molecules like MHC class I molecules expressing only by host cells. A high secretion 
of MHC class I molecules protects cells from NK cells attack.  During cancer or viral 
infection the expression of MHC class I molecules is often decreased. Thus NK cells 
are able to recognize and remove pathogens, tumors and virus-infected cells. Target 
cells are killed by secreted granules containing membrane-distinguishing peptide, 
perforine, serine protease and ganzyme. But a presence of MHC class I and other 
molecules is not restricted to host cells because some cytotoxic cells are also capable 
to release this kind of molecules (Danilova 2006). 
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1.3 Cross-talk between intestinal epithelium and the microbiom 
Intestinal epithelial cells interact and response to environmental signals by secretion 
of chemokines and cytokines to activate an innate and/ or adaptive immune response. 
Whereas the nature of response is depend on the kind and location of stimulation. For 
instance, the presences of commensal bacteria lead to high amounts of IgA without the 
use of adaptive immune system. But the production of sIgA against specific pathogens 
requires the interaction of T and B cells in Peyer’s patches or antigen-presenting cells 
within lymphoid tissues (Galdeano et al. 2007). 
 
1.3.1 Epithelial cell recognition of commensal bacteria by TLRs and NLRs  
Intestinal epithelial cells (IECs) express pattern recognition receptors such as Toll-
like receptors (TLRs) and NODs-like receptors (NLRs) on apical or basolateral 
surface. TLRs recognize different kinds of bacterial molecules (like describe above). 
Under steady-state condition there are only a slight or no expression of TLR2 and 
TLR4 on apical surface leading to a diminished recognition of bacterial 
lipopolysaccharid (LPS). It was observed that other TLRs and NLRs localizing in 
subcellular regions may facilitate the discrimination of commensal or pathogenic 
bacteria. For instance, TLR5 recognizing bacterial flagellin is exclusively expressed 
on basolateral surface of IECs. TLR3, TLR7, TLR8 and TLR9 are expressed in 
intracellular endosomal organelles and some NLRs are found in the cytoplasm of 
IECs. Thus TLRs and NLRs on basolateral surface recognize only pathogenic (or 
commensal) organism overcoming the epithelial cell barrier. Ligation to these 
receptors elicit an innate immune response including initiate expression of pro-
inflammatory cytokines and chemokines as well as anti-microbial peptides (Artis 
2008). Commensal LPSs and peptidoglycans help to maintain the gut homeostasis and 
protect the mucosa from cell damages through inducing the expression of protective 
cytokines such as IL-6, TGF-β, KC-1 and diverse heat shock proteins (Dinalo and 
Relman 2009). Usually a TLR ligation induces the NF-κB pathway or nitrogen-
activated protein kinase (MAPK) leading to an inflammatory response, but do not 
cause an inflammatory diseases after a stimulation of commensal bacteria. This 
tolerance against commensal is caused by varied anti-inflammatory/ inhibitor 
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mechanisms- one of them is described below. This cross-talk is crucial to maintain the 
epithelial integrity. Dsyregulation of the commensal- TLRs interaction can results in 
inflammatory diseases (Kelly et al. 2005; Clark and Coopersmith 2007; Artis 2008).  
The NF-κB pathway is the most important pro-inflammatory signaling cascade of the 
innate immune response because NF-κB regulates and controls the gene expression of 
several inflammatory mediators like cytokines. During an absence of initiate signals 
NF-κB is bound to the inhibitor ligand IκB in the cytoplasm. Stimulating signals 
result in an IκB phosphorylation by IκB-kinase. A following ubiquitin-dependent 
degradation split NFκ-B from IκB. The activated NF-κB migrate from the cytoplasm 
to the nucleus where it promotes the transcription of some target genes involving in 
inflammatory response (Artis 2008; Won-Jae 2008). 
Pathogen-associated molecular pattern like LPS and peptidoglycan elicit a NF-κB-
dependent inflammatory response but it does not lead to an inflammation. Because 
there are many regulatory mechanisms including bacterial-mediated regulation like 
the promotion of nuclear-cytoplasmic retribution of NF-κB through peroxisome 
proliferation-activated receptor-γ pathway (Won-Jae 2008). For instance, the 
neddylation of cullin-1 by Ubc12 is needed for a correct arrangement of enzymatically 
active SCF complex. A commensal-bacteria-mediated production of reactive oxygen 
species (ROS) results in an inactivation of Ubc12. Therefore the neddylation of cullin-
1 by Ubc12 is not possible and cullin-1 associated and neddylation-dissocated protein-
1 (CAND 1) is capable to bind to the deneddylated form of cullin-1 which leads to an 
inactive SCF complex. Under inflammatory conditions the formation of NEDD8-
UBC12 thioester complex activates the SCF complex. The activated SCF complex is 
involved in the ubiquitin-dependent degradation of IκB leading to activated NF-κB 
which promotes the transcription of inflammatory genes. This bacterial-regulated IκB 
stabilization through ROS is an example for coexist of commensal bacteria within the 
GI tract without causing inflammation. Whereas some commensal bacteria have a 
higher potential as ROS-inducer than other bacteria. A dysregulation of NF-κB 
pathway is associated with the pathogenesis of chronic inflammatory bowel diseases 
(Won-Jae 2008). 
 
SCIENTIFIC BACKGROUND 27 
 
1.3.2 Epithelial integrity 
The epithelium has a function as physical barrier between human organism and 
exogenous environment. A critical parameter of barrier function is the permeability of 
the epithelium. Tight junctions are involved in the regulation of epithelial 
permeability. They connect epithelial cells with each other and form a physical as well 
functional barrier against paracellular invasion of pathogenic substance from the 
intestinal lumen. Cytokines are crucial modulators of the expression and the 
localization of tight junctions (Clark and Coopersmith 2007). For instance, pro-
inflammatory cytokines such as TNF-α, IFN-γ, IL-4 and IL-13 are associated with an 
increased permeability. Whereas cytokine IL-10 preventes the pro-inflammatory-
induced augmentation of permeability. A leakage of the tight junction barrier as well 
as intestinal barrier can leads to an increased intestinal permeability and in the 
following to a penetration of luminal antigens into the epithelium which cause an 
inflammatory response (Clark and Coopersmith 2007; Hörmannsperger and Haller 
2010). Such as TNF-α reduces the expression of ZO-1 protein and changes the 
protein localization. A reduction of ZO-1 protein triggers the expression of inducible 
nitric oxide synthase (iNOS) leading to an enhanced synthesis of nitric oxide (NO) 
within the intestinal epithelial cells. NOs play an essential role in homeostasis and 
development of diseases. Endogenous NO is needed to maintain the mucosal 
permeability. A disorder in NO production is dangerous for intestinal integrity (Clark 
and Coopersmith 2007). 
Furthermore, apoptosis, the programmed cell death, is an important regulatory 
mechanism which is also influenced by commensal bacteria. Apoptosis is initiated by 
receptor-mediated pathway or by mitochondrial-mediated pathway. Apoptotic cells 
release several signaling molecules influencing the surrounding cells. In general, a 
decreased level of apoptotic cells within the GI tract is associated with the secretion of 
anti-inflammatory cytokines and the suppression of pro-inflammatory cytokines 
(Clark and Coopersmith 2007).   
Permeability and apoptosis of intestinal epithelial cells interact with each other. For 
instance, in rats with an increased permeability were observed a higher level of 
apoptotic cells (Clark and Coopersmith 2007). A reduction of intestinal barrier 
function induced by bacterial stimulation leads to a dysregulation of inflammatory 
signals and augmented apoptosis level (Hörmannsperger and Haller 2010). 
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1.4 How probiotic bacteria influence the immune response within the GI tract 
Probiotic bacteria affect the host in different ways. They influence the composition of 
intestinal microbiota, the intestinal barrier function and modulate the innate as well as 
the adaptive immune system. Whereas different probiotic strains and their products 
induce a variance of different protective mechanisms (Delcenserie et al. 2008; 
Hörmannsperger and Haller 2010). Clinical relevance has Escherichia coli Nissle 1917 
and the probiotic mixture VSL#3 containing following 8  bacteria species: 
Lactobacillus acidophilus, Lactobacillus bulgarius, Lactobacillus casein, Lactobacillus 
plantarum, Streptococcus thermophilus, Bifidobacterium breve, Bifidobacterium infantis and 
Bifidobacterium longum (Hörmannsperger and Haller 2010). Probiotic bacteria have to 
interact with the epithelial cells and/ or intestinal immune cells to promote an 
immune response. For instance, bacterial flagellin binds to TLRs and induces an 
immune response.  But probiotic organism also interact with M-cells of Peyer’s 
patches and may be is also collected by dendritic cells  (Hörmannsperger and Haller 
2010). 
 
1.4.1 Probiotic bacteria and epithelial integrity 
An increased apoptosis within intestinal epithelial cells (IECs) is often associated with 
the penetration of pathogenic microorganisms. In ulcerative colitis patients were 
observed a higher level of apoptotic epithelial cells and a reduced intestinal barrier 
function. In gnotobiotic mice, Escherichia coli Nissle up-regulated the expression of 
tight junction protein ZO-1. In vitro E. coli Nissle prevented the penetration of 
pathogenic bacteria such as Salmonella dublin, Yersina entercolitca, Shigella flexuri, 
Legionella pneumophilla and Listeria monocytogenes through secretion of soluble factors. 
That indicates an anti-apoptotic effect of E. coli Nissle. Such an anti-apoptotic effect of 
probiotic proteins is dependent on simultaneous stimulation of heat shock protein 
(HSP) production in IECs. For instance, pro-inflammatory cytokines TNFα and IFN-
γ suppress the expression of cytoprotective HSP like hsp25 und hsp70 which augment 
the number of apoptotic cell within epithelium (Hörmannsperger and Haller 2010). 
Lactobacillus rhamnosus GG releases the proteins p40 and p75 blocking the TNFα-
induced pro-apoptotic signal pathway and trigger the Akt-dependent survival 
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pathway in IECs (Fang et al. 2007). 
1.4.2 Probiotic bacteria and immunomodulation function 
The immunomodulation function of probiotic bacteria to the intestinal epithelial cells  
(IECs) are depend on bacteria species and strain as well as bacterial immune-derived 
stimulation (Delcenserie et al. 2008; Hörmannsperger and Haller 2010). Like describe 
above, IECs are capable to detect components of microbiota by expression of TLRs or 
cytolic NLRs and through MHC class II detection and co-stimulatory proteins. A 
continuing activation of NF-κB by increased expression of chemokine IL-8 or 
RANTES and IP-10 are crucial signal molecules in the development of chronic 
inflammation within the GI tract. Because a dysregulated, steady synthesis and 
expression of these chemokines lead to an persistent recruitment and activation of 
effector cells such as T cells, neutrophils and macrophages in the mucosal tissue. A 
pro-inflammatory response is required to fight against potential pathogenic 
organisms. In healthy humans this response is terminated after a successful 
elimination of infection. For instance, Lactobacillus plantarum plays a role in the 
modulation of NF-κB- dependent pathway in duodenal mucosa. And soluble factors of 
E. coli Nissle block the TNFα-mediated expression of IL-8 in IECs. It was also 
observed that VSL#3-derived DNA decreased the expression of IL-8 in IECs. This 
effect was initiated by probiotic bacteria which reduce the protosomal activity in IECs 
leading to suppressed degradation of IκB, the inhibitor of NF-κB, in IECs. A mix of 
soluble probiotic proteins were able to inhibit a Salmonella-dublin-induced activation of 
NF-κB. Lactobacillus casein, extracted from VSL#3, shown a specifically inhibition of 
IP-10 expression in IECs resulting in a decreased recruitment of activated T 
lymphocytes. The priming of naive T cells into effector or regulatory T cells is 
depends on cytokines milieu and depends on co-stimulatory signals from antigen-
presenting cells. Probiotic bacteria are capable to effect pro-inflammatory cytokines 
expression; inducing effector T cells development as well as anti-inflammatory 
cytokines mediated development of regulatory T cells. As an example, VSL#3 
promotes an anti-inflammatory response by induction of mucosal CD4+CD25+ and 
CD4+ LAP positive regulatory T cells. VSL#3 also increased the transcription of 
regulatory Foxp3. In pouchitis patients VSL#3 suppressed the expression of pro-
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inflammatory IL-1β. And in patients with ulcerative colitis a treatment with the 
bacteria mixture VSL#3 reduced the expression of IL-8 as well as IFN-γ and IL-1β in 
dendritic cells or T cells (Hörmannsperger and Haller 2010).  
 
Figure 2: Overview of immunomodulated effect of Lactobacilli and Bifidobacteria (Boesten and de Vos 2008) 
 
IL-1β induces an IL-6 expression and production. Lactobacillus paracasein ssp. 
paracasein F19 and Lactobacillus plantarum 2362 (108 cells/ml) did not affect the IL-6 
production in Caco-2 cells, but the combination of IL-1β with one of these viable 
bacteria or heat-inactivated or sonicated bacteria led to an increase of IL-6  
concentration by 6-fold in case of L. paracasein F19 and by 2-fold in case of L. 
planatrum 2362 compared to IL-1β stimulation alone. That was also reflected in an 
augmentation of IL-6 mRNA level in a time-dependent manner. The commensal 
vaginal bacteria Lactobacillus jensinii as well as the non-pathogenic E. coli DH5α in 
combination with IL-1β showed a slight rise of IL-6 production. These results 
indicate that probiotic bacteria or their cell wall components in combination with IL-
1β are able to improve the IL-6 production in Caco-2 cells. Whereas this affect is 
strain-dependent. This beneficial effect could be relevant for clinical treatment of 
bowel inflammation. The combination of TNF-α and L. paracasein F19 did not led in a 
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measurable IL-6 production which indicate L. paracasein have no influence on IL-6 
production via TNF-α pathway (Reilly et al. 2007). Vinderola et al used small 
intestinal epithelial cells (SIEC) of mousses to study the effect of probiotic 
Lactobacillus casein CRL431 and Lactobacillus helveticus R389 as well as non-pathogenic 
E. coli MM245 to the IL-6 production. All bacteria showed a reduction of IL-6 
concentration at a concentration of 108cells/ml and an augmentation, especially a 2-
fold increase after E. coli stimuli, at a concentration of 106 and 107bacteria/ml. After a 
treatment of non-viable bacteria the IL-6 production was greater as with viable-
treated SIEC. An ex-vivo test with this mouse model and an oral admission of 
probiotic bacteria found L. casein increased the IL-6 concentration by about 8-fold 
after two days and about 2-fold after day 5 and 7. L. helveticus led to a rise of IL-6 by 
8-fold after the second day and an increase by 3-fold after day 5 and 6-fold after day 7. 
This study shown epithelial cells in natural context have a higher capacity to influence 
the IL-6 production (Vinderola et al. 2005). 
Further, Lactobacillus plantarum reduced the LPS (from Salmonella enterica serovar 
typhimurin)- induced IL-23 expression and protein secretion, and thus shown also anti-
inflammatory properties (Paolillo et al. 2009). 
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1.5 The Interleukin 8 
1.5.1 The role of IL-8 in the immune system 
Interleukin 8 (IL-8) is a member of CXC-chemokines, also term as chemotractic 
cytokine. A wide variety of human cells such as endothelial cells, fibroblasts from 
different tissues, several types of epithelial cells and tumor cells are capable to secrete 
IL-8 in response to various pathogenic microbes and pro-inflammatory cytokines such 
as tumor necrosis factor (TNF) and IL-1. The IL-8 expression is regulated at the 
transcriptional level by the nuclear factor (NF)-κB. IL-8 and other CXC-chemokines 
are capable to recruit neutrophils (Baggiolini et al. 1995; Remick 2005; O’Hara et al. 
2006). As a neutrophil chemoattractans, IL-8 induces chemotaxis leading to the 
migration of neutrophils to the site of inflammation and results in some shape changes 
including transient augmentation of intracellular Ca-ion, secretion of granule 
contents, up-regulation of adhesions proteins, formation of bioactive lipids and 
respiratory burst (Baggiolini et al. 1995). Because IL-8 plays a crucial role in  the 
regulation of inflammatory response and its relative longevity at site of acute 
inflammation, it is used as mediator of inflammation (Baggiolini et al. 1995; Remick 
2005). 
 
1.5.2 Influence of bacteria to IL-8 expression and protein level 
During the last years several studies researched the affect of pathogenic and 
commensal bacteria, some of them are (potential) probiotic bacteria, to the IL-8 
expression as well as IL-8 secretion. A study with three different human intestinal cell 
lines (Caco-2, HT-29 and HCT 116) shown Enterococcus feacalis (EC1, EC3, EC15, 
EC16) down-regulate the IL-8 production in all cell lines. In Caco-2 cells Lactobacillus 
delbrueckki bulgaris D1, Lactobacillus rhamnosus GG, Lactobacillus paracasein LP33, 
Lactobacillus brevis T6 and Streptococcus thermophilus NCIMB10387 also inhibited the 
IL-8 secretion. But the IL-8 mRNA level was increased by 107cfu/ml of E. feacalis 
(EC1, EC3, EC15, and EC16), L. rhamnosus GG and L. bulgaris D1. And there were 
not observed any alternation in IL-8 mRNA expression with bacteria by 108 cfu/ml 
(Wang et al. 2008). These data of IL-8 expression are not consistent with IL-8 protein 
concentration indicating there have to be involved post-transcriptional or post-
SCIENTIFIC BACKGROUND 33 
 
translational mechanisms. 
Caco-2 cells, pre-treated with live or UV-inactivated L. rhamnosus GG, shown a 
decreased IL-8 production by 66% or 59% after stimulation with flagellin of 
Pseudomonas aeruginosa  compare to the flagellin stimulation alone  which led to a 17-
fold increase of IL-8 production. Live L. rhamnosus GG alone induced an IL-8 
expression by 2-fold. Whereas UV-inactivated L. rhamnosus GG alone had no 
influence to IL-8 expression (Lopez et al. 2008). A further experiment studied the 
impact of Bifidobacterium animals MB5 and L. rhamnosus GG to an enterotoxigenic E. 
coli K88 (ETEC)-induced pro-inflammatory response. ETEC alone induced a strong 
up-regulation of IL-8 expression as well as IL-1β and TNF-α and a down-regulation 
of TGF-α expression. Both bacteria, L. rhamnousus GG and B. animalis MB5, reversed 
the ETEC-induced effect to the expression of IL-8, IL-1β and TNF-α to the level of 
untreated cells and up-regulated the TGF-α expression to the basal level. Like 
describe above the cytokines IL-1β and TNF-α are positive associated with IL-8 
expression. It is known that TGF-α inhibits the IL-1β expression and also influence 
the IL-8 expression. Thus B. animals and L. rhamnosus GG have an anti-inflammatory 
effect to an ETEC-induce inflammatory (Roselli et al. 2006). In Caco-2 cells pre-
treated with supernatant of Lactobacillus casein subsp. casein 2756, Lactobacillus carvatus 
2775 and L. platarum 2142 were observed a reduction of Salmonella enteritidis- 
mediated IL-8 production by 3- to 5-fold compare with the rise of S. enteritidis alone 
(Nemeth et al. 2006). Pathogenic bacteria including Vibrio cholera O1 and V. cholera 
O139, enterohaemorrhagic Escherichia coli (EHEC), Salmonella typhimurin and Shigella 
flexneri induced a IL-8 production in HT29 and T84 cell lines. The probiotic bacteria 
Lactobacillus rhamnosus GG and Lactobacillus plantarum alone did not affect the IL-8 
secretion, but pre- or co- cultured with the pathogenic bacteria resulted in a 
suppressed IL-8 secretion caused by V. cholera, S. typhimurin and EHEC. The both 
lactobacilli did not influence the Shigella-induced IL-8 production (Nandakumar et al. 
2009). Similar effects were shown for Bifidobacterium infantis and Lactobacillus 
salivarius which reduced the IL-8 secretion in a dose-dependent manner in untreated 
HT-29 cells and also inhibited the S. typhimurin-induced IL-8 secretion by 23.5% or 
31%. Further, B. infantis inhibited the IL-8 secretion caused by flagellin of S. 
typhimurium, but not L. salivarius (O’Hara et al. 2006). In contrast, Vizoso Pinto et al 
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observed in their experiment that HT29 cells pre-treated with L. plantarum BFE 1685 
or L. rhamnosus GG and infected with S. typhimurium led to an augmented IL-8 
concentration by about 2.5-fold (Vizoso Pinto et al. 2009).  Further, an inhibitory 
effect on IL-8 production caused by Listeria monocytogenes was observed in C2Bbe1 cell 
culture which was pre-treated with Lactobacillus salivarius UCC118 or Lactobacillus 
acidophilus NCDO 1748, Lactobacillus casein NCDO 1205, Lactobacillus lactis NZ9000 
and Bifidobacterium breve UCC2003, B. infantis CCUF36569 as well as Bifidobacterium 
longum JCM 7050 (Corr et al. 2007). 
For instance, IL-8 production is mediated by TNF-α. In Caco-2 cells with and 
without antibiotics were shown that L. rhamnosus GG inhibited the TNF-α up-
regulation at a concentration of 106 and 108 cfu/ml. L. rhamnosus GG at a 
concentration of 1010 cfu/ml increased explicit the IL-8 production in a TNF-α-
dependent manner, equal if in media with our without antibiotics. Heat-killed L. 
rhamnosus GG also blocked the TNF-α-induced IL-8 up-regulation at a concentration 
of 106 and 108 cfu/ml, but a concentration of 1010 cfu/ml led to a slight rise of IL-8 
production without TNF-α (Zhang et al. 2005). Jea Sung Ko et al observed the same 
inhibitory effect of TNF-α-induced IL-8 secretion for Lactobacillus plantarium ATCC 
8014 at a concentration of 107 cfu/ml (Jae et al. 2007). TNF-α pre-treated HT-29 cells 
shown a higher IL-8 concentration by 2.5- to 3-fold after addition of Lactobacillus 
plantarum BFE 1685 and Lactobacillus rhamnosus GG (Vizoso Pinto et al. 2009). 
Contrary to this finding, McCracken et al observed indeed an increase of IL-8 mRNA 
level by 6.6- fold in HT-29 cells pre-treated with TNF-α and incubated with L. 
plantarum 299v compare to HT-29 cells treated with TNF-α alone. But this higher IL-
8 gene expression did not result in an augmentation of IL-8 protein concentration.  In 
contrast, TNF-α pre-treaded HT-29 cells shown a reduction of IL-8 level after 
addition with L. plantarum 299vb (McCracken et al. 2002). A dose-dependent 
inhibition of TNF-α- induced IL-8 production was also shown for Bifidobacterium 
longum Bar33 and Lactobacillus acidophilus Bar13 as well as a mixtures of them 
(Candela et al. 2008). 
IL-1β induces a lower IL-8 production compare to TNF-α.  In Caco-2 cells  the 
combination of IL-1β with Lactobacillus paracasein F19 did not affect the IL-8 
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concentration (Reilly et al. 2007). HT-29 cells, pre-treaded  with IL-1β, shown a 
reduced IL-8 level after incubation with Bifidobacterium longum Bar33 and Lactobacillus 
acidophilus Bar13 as well as a mixtures of them (Candela et al. 2008). The 
lipopolysaccahride (LPS) from E. coli O55:B5 (100 ng/ml) blocked the IL-1β as well as 
TNF-α induced IL-8 secretion, but did not affect the IL-6 concentration in Caco-2 
cells (Savidge et al. 2006). 
These data show probiotic bacteria at a moderate level have a beneficial influence on 
IL-8 production mediated by pro-inflammatory cytokines and/or chemokines as well 
as pathogens. But this effect seems to be species- and strain-specific. 
 
 
1.6 The Interleukin 17  
1.6.1 The role of IL-17 in the immune system 
The distinctive cytokine Interleukin (IL-) 17 is major released by TH17 cells. But also 
nature killer cells and nature killer T cells are able to express it. The differentiation of 
naïve T cells into TH17 cells is mediated by IL-6 and TGF-β- dependent expression of 
the transcription factor ROR-γt. IL-23 regulates the expansion as well as survival of 
TH17 cells. Interleukin 17 occurs relative at the end of an inflammatory cascade 
(Miossec et al. 2009). Nowadays six subsets from IL-17A to IL-17F are known, 
whereas IL-17E is also termed as IL-25. The IL-17 family members are expressed in 
different cells of tissues or organs. The most important subsets are IL-17A, also called 
as IL-17, and IL-17F which are quite similar to each other (Kolls and Lindén 2004; 
Gaffen 2009). The primary target cell type are neutrophils which induce an 
inflammatory response through expression of IL-1β, TNF-α, IL-6 and some 
chemokines involving in neutrophil recruitment such as IL-8 (Maloy and Kullberg 
2008; Miossec et al. 2009). Further target cells include endothelial cells, fibroblasts, 
osteoblasts and chondrocytes. In addition to its function as pro-inflammatory cytokine 
it is also involved in the control of extracellular pathogens, inducing matrix 
destruction and has synergy effects with TNF-α and IL-1β. An overproduction of IL-
17 is associated with chronic inflammation and serve immunopathologic conditions 
(Miossec et al. 2009). 
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1.6.2 The affect of bacteria on IL-17 production 
An experiment with germ free (GF) mice and conventionally reared (CNV) mice 
showed an increased IL-17 gene expression by 2-fold in the large intestine of GF mice 
compare with them of CNV mice. Further, in the large intestine the IL-17 mRNA 
level was 3-fold higher in antibiotic treated CNV mice then in CNV mice. There was 
no significant alternation in the small intestine. Zaph et al also found GF mice treated 
with IL-25 have a lower IL-17 mRNA level in the large intestine compare with GF 
mice. And the commensal-dependent expression of IL-25 reduced the IL-23 
concentration and the frequency of TH17 cells in the large intestine. That suggests 
commensal bacteria have an inhibitor effect on IL-17 expression in the large intestine 
(Zaph et al. 2008). The IL-17 production in the lamina propria of small intestine in 
BALB/c mice was not affect by supplementation of Lactobacillus acidophilus A9, L. 
acidophilus 1462, Lactobacillus casein CRL 431 and Escherichia coli 129 after two days as 
well as after day 5 and 7. Only E. coli 13-7 induced an IL-17 production in a time-
dependent manner. Dogi et al assume this observation is associated with an 
augmentation of IFNγ and IL-12 which have a suppressive affect on IL-17 expression 
(Dogi et al. 2008).  
It was shown that IL-27 inhibits the IL-17 production. Murine splenocytes treated 
with TGF-β plus IL-6 led to a drastic increase of IL-17 production and a lower IL-27 
concentration. The addition of heat-killed Bifidobacterium infanits to these murine 
splenocytes reduced the TGF-β and IL-6 induced IL-17 production and increased the 
IL-27 secretion. Whereas heat-killed Bifidobacterium bifidum led to a higher IL17 
concentration and heat-killed Lactobacillus acidophilus and Lactobacillus bulgaris induced 
a slight IL-17 production and a reduction of IL-27. That indicates bacteria modulate 
the IL-17 production in a species-dependent manner. In this experiment IL-17 level is 
negative correlated with IL-27 level in TGF-β and IL-6 treated cell. Further, in colon 
organ culture  heat-killed B. bifidum, B. infantis and Bifidobacterium cantenulatum 
decreased the dextran sodium sulfate-induced IL-17 production without changes in 
IL-27 production (Tanabe et al. 2008). An increase of IL-17 production after addition 
with B. bifidum was also observed in human monocyte-derived dendritic cells. 
Whereas this effect seems to be strain-specific (López et al. 2010). 
SCIENTIFIC BACKGROUND 37 
 
1.7 The CASP 3 gene 
1.7.1 Caspase-3 and apoptosis 
Caspase-3 is a member of caspases, a class of proteolytic enzymes which are essential 
for the apoptosis. Apoptosis is an active and energy-dependent programmed cell death 
occurring in presence or absence of caspase activation. Mostly the cell death is 
caspase-mediated and thus executioner caspase such as CASP3, CASP6 and CASP7 
leading directly to apoptosis and can used as markers for cell death. There are two 
apoptotic signaling pathways. The extrinsic pathway, also named as death-receptor 
pathway, is activated through ligation to death receptors like tumor necrosis factor 
receptor (TNFR) and Fas. This stimulation leads to a recruitment of pro-caspase 8 
and activation (cleavage) of caspase 3. The intrinsic pathway or mitochondrial/ER 
pathway is induced through cytokines like IL-1 and IL-6, chemokines and growth 
factors. In this pathway bcl-2 family members and disintegration of the mitochondrion 
also induce caspase 3 activation. The homeostasis of apoptosis is important for 
intestinal epithelial development and their function (Perl et al. 2005). 
 
1.7.2 How bacteria influence caspase-3 activation 
In dextran sodium sulfate (DSS)-induced colitis mice a treatment with Bacillus 
polyfermenticus led to a lower number of apoptotic cells in colonic mucosa. Human 
colonic epithelial cells which were treated with apoptosis-inducing factor FasL or 
Clostridium difficiletoxin A, shown in presence of B. polyfermenticus-conditioned medium 
a strong reduction of FasL. C. difficiletoxin A induced PARP cleavage and an 
inhibition of caspase-3 cleavage inducing by C. difficiletoxin A. That indicates soluble 
factors from B. polyfermenticus are able to suppress apoptosis in colonic mucosa as well 
as colonic epithelial cells (Eunok et al. 2009). 
In an experiment with Caco-2 cells which were co-cultured with Atopobium minutum, 
Lactobacillus rhamnosus GG, Bifidobacterium lactis Bb12, non-pahtogenic Escherichia coli 
K-12 strains and pathogenic E. coli (EPEC and VTEC), was observed a translocation 
of BAX and BAK, both Bcl-2 family members, into mitochondrion for all bacteria 
without an augmentation of BAX or BAK concentration. Whereas this translocation 
was 2- to 3-fold higher after the treatment with pathogenic E. coli. Further all 
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bacteria, with the exception of E. coli K-12 strains, showed an activation of caspase-9 
and a reduction of pro-caspase 9 leading to proteolytic cleavage of caspase-3. Thus 
pathogenic E. coli, the used probiotic bacteria and A. minutum have an apoptosis-
inducing effect in colon cancer Caco-2 cells (Altonsy et al. 2010). A treatment of Caco-
2 cells with Lactobacillus rhamnosus GG, L. rhamnosus Lc705, Propionibacterium 
freundenreichii subsp. shermanii, Bifidobacterium breve Bb99 and pathogenic Helibacter 
pylori resulted only in the case of P. shermanii in an increased caspase-3 activity.  In 
bacteria pre-treated Caco-2 cells infecting with H. pylori were observed a reduced 
caspase-3 activity under the control level for the pre-treatment with L. rhamnosus GG, 
L. rhamnosus Lc705 and the combination of all four bacteria after 24 h suggesting a 
preventive role in caspase-3 activity in H. pylori infected Caco-2 cells (Myllyluoma et 
al. 2008). An anti-apoptotic effect for L. rhamnosus GG was also shown in an 
experiment with in vitro intestinal epithelial cells and in ex- vivo with cells of the 
murine gut of two week-old mices feeding oral with viable L. rhamnosus GG. In these 
experiments could decreased a chemical-induced caspase-3 activation and the number 
of epithelial apoptotic cells (Lin et al. 2008). Further, the pro-apoptotic effect of the 
genus Propionibacteria was observed in a study with P. acidipropionici CNRZ80, P. 
freundenreichii subsp. freudenreichii ITG18 and P. freudenreichii subsp. shermanii SI41 
where it could be shown that the short-chain fatty acids (SCFAs) propionate and 
acetate producing by these bacteria, inducing the cleavage of procaspase-3 as well as 
the activation of caspase 3 in HT-29 and Caco-2 cells. The Propionibacteria were even 
able to kill the both human colon cancer cell lines. Whereas the extent of cytotoxic 
effect is depend on the produced SCFAs amount (Jan et al. 2002). 
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1.8 Characterization of bacteria 
1.8.1 Lactic acid bacteria 
Lactic acid bacteria (LAB) are inhabitants of the human and animal gastrointestinal 
tract. Some species are used for the production of dairy or other fermented foods or as 
probiotic food. The most three important genera are Lactobacillus, Bifidobacteria and 
Streptococcus. Further common LAB contain species of Enterococcus and Lactococcus. 
LAB are gram positive, non-spore forming and usually catalase negative bacteria 
growing under microacophilic or strictly anaerobic atmosphere. They are capable to 
ferment carbohydrates often to the end product lactic acid. Other properties contain 
resistance to low pH and/ or bile, tolerate different concentration of NaCl and are 
often resistance against antibiotics. Furthermore, LAB are capable to grow under 
conditions of different nutrient media and defined temperatures (Klein et al. 1998). 
 
1.8.1.1 Lactobacillus acidophilus NCFM 
Lactobacillus acidophilus NCFM is a common probiotic strain using in conventional 
foods like milk, yoghurt, toddler formula and juices, as well as in dietary supplements 
in the United States of America since the mid-1970s. This strain has an excellent 
stability within milk and fermented dairy products insolated with a density of about 
107cfu/ml. Toxonomical Lactobacillus acidophilus NCFM is a strain of type A1 L. 
acidophilus, a gram-positive and catalase-negative homofermenter that ferments 
carbohydrates to 34% D- and 66% L- lactic acid. From the three chosen probiotic 
bacteria, L. acidophilus produced the highest amount of lactic acid and lower explicit 
the pH in its fermented products. Like all probiotic strains L. acidophilus NCFM is 
able to tolerate low pH condition and is capable to adhere to intestinal epithelium. In 
studies with Caco-2 cells, an enhanced attachment was observed in the presence of 
calcium ions. Further, this probiotic strain survives the gastrointestinal transit in 
healthy as well as sick humans. The properties to produce anti-microbial compounds 
such as lactic and acetate acid, hydrogen peroxide, diacetyl, bacterial or bacteriostatic 
peptides and proteins, are necessary for competitive exclusion of pathogens including 
Staphylococcus aureus, Salmonella typhimurin, enterpathogenic Escherichia coli and  
Clostridium perfringens. Other beneficial attributes are reducing the incidence of 
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pediatric diarrhea, decreasing the concentration of toxic amines in blood of dialysis 
patients with small bowel bacterial overgrowth and decreasing the cholesterol level. 
An adequate daily intake of L. acidophilus NCFM may facilitates the lactose 
digestion in lactose-intolerant individuals (Sanders and Klaenhammer 2001). A 
prophylaxis supplementation to children between 3 and 5 years of age with L. 
acidophilus NCFM alone or in combination with Bifidobacterium animalis subsp. lactis 
Bi-07 during the six winter months reduced explicit the incidence of fever, cough and 
rhinorrhea as well as the duration of illness and the use of antibiotics. There are 
certain strains of probiotic bacteria being a safe and effective way to prevent cold and 
influenza-like symptoms in children. Whereas L. acidophilus NCFM alone was 
effective, but in combination with Bifidobacterium animals subsp. lactis  Bi-07 was 
shown a boarder protective effect (Leyer et al. 2009). Moreover the consumption of L. 
acidophilus NCFM in combination with the prebiotic lactitol led in elderly persons 
who take NSAID, to an increased stool frequency without side-effects and to a higher 
level of faecal L. acidophilus NCFM and Bifidobacteria. This measured level is similar 
to reported Bifidobacteria concentration of healthy young adults. And the 
concentration of PGE and spermidine were also increased. These data indicate that 
the consumption of L. acidophilus NCFM with lactitol enhance mucosal function and 
alter the microbiota composition (Ouwehand et al. 2008). In a study with isolated 
intestinal epithelial cells from a mouse fetuses L. acidophilus NCFM resulted in a 
slower but higher production of cytokines and chemokines than E. coli Nissle. E. coli 
Nissle induced a up-regulation of IL-6, IL-10 and TNF after 2 h and shown a down-
regulation of IL-10 after 4 h. Whereas L. acidophilus NCFM achieved a similar 
expression level of IL-6 and TNF after 4 h and shown the highest protein 
concentration after 18 h. Interestingly, E. coli Nissle stimulated the transcription of 
TLR-2, a receptor to detect gram-positive bacteria, and inhibited the transcription of 
TLR-4 which is a LPS receptor. Thus E. coli may induced a L. acidophilus NCFM- 
mediated  slower but potentiated up-regulation through an increase level of TLR-2 
(Zeuthen et al. 2010).  
L. acidophilus NCFM also influence the cytokines expression in dendritic cells (DC) 
in a dose-dependent manner. The anti-inflammatory cytokines IL-10 and IL-6 were 
SCIENTIFIC BACKGROUND 41 
 
higher expressed at an increasing concentration of L. acidophilus NCFM (at a ratio 
1:100 DC/bacteria cells). Whereas IL-12p70 expression was increased at lower 
bacteria concentration suggesting a beneficial effect of L. acidophilus NCFM because 
a higher amount of DCs express more IL-10 and IL-6 which is associated with the 
capability to modulate the T cells maturation forward Th17 or regT cells (Konstantinov 
et al. 2008). 
 
1.8.1.2 Bifidobacterium animalis subsp. lactis Bt420 
Bifidobacterium animalis subsp. lactis Bt420 (B. lactis Bt420) is a gram-positive, non-
motile and anaerobic bacterium which produces short chain fatty acids like acetate and 
lactate but do not produce butyrate and propionate. Further, B. lactis strains 
synthesize folic acid (Nurmi et al. 2005) and show an anti-microbial activity against 
Staphylococcus aureus and E. coli. Its probiotic properties are associated also with the 
capability to adheres to human mucus in subjects of different age groups (Klein et al. 
2008).  The consumption of the combination of L. acidophilus 74-2 (2.8 x 109 cfu/day) 
and B. lactis 420 (9.0 x 108 cfu/ day) led to an increased proportion of both bacteria in 
fecal samples after the intervention period of 5 weeks. That indicates a transient 
colonization of these bacteria. In addition a rose level of granulocytes and monocytes 
with an higher phagocytic activity was observed during the probiotic intervention 
period suggesting the combination of this both bacteria strains are able to affect the 
unspecific cellular immune response. The supplementation also resulted in a lower 
serum concentration of triacylglyceroles but did not affect the serum cholesterol 
(Klein et al. 2008). A similar study with a probiotic drink containing Lactobacillus 
paracasein Lpc-32, L. acidophilus 74-2 and B. lactis 420 compared the influence of 
probiotic between healthy adults and atopic dermatitis (AD) patients. In addition to 
the results as described above, in healthy persons an increase of CD57+ and a decrease 
of CD3+ CD4+ were observed after the consumption of this probiotic drink. These 
results indicate an immune stimulating effect of the probiotic drink which may leads 
to a lower incidence and duration of infection among healthy individuals. AD patients 
showed a reduction of SCORAD by 15.5% and lower level of CD4+ and CD54+, but no 
alternation among major lymphocytes and nature killer cells after probiotic 
supplementation. The beneficial effect on therapy of AD patients is only shown for 
mild and moderate AD. This findings further suggest probiotic foods affect the 
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peripheral immune parameters depend on immune status of an individual (Roessler 
(nee Klein) et al. 2007). 
Caco-2 cells stimulated with B. lactis 420 supernatant showed a higher transepithelial 
electrical resistance (TEER). In contrast supernatant of pathogenic Escherichia coli 
O157:H7 (EHEC) led to a strong decrease of TERR indicating a damage of tight 
junction. Interestingly, in Caco-2 cells pretreated with B. lactis 420 supernatant, the 
EHEC-induced tight junction damage could prevented (Putaala et al. 2008).  
Furthermore, the addition of B. lactis 420 to Caco-2 cells led to a strong increased 
expression of Cox-1 playing amongst others a crucial role in the maintenance of 
gastrointestinal integrity and has a cytoprotectiv function within the GI tract. And it 
led to a reduction of Cox-2 expression whereas a high expression of Cox-2 gene is 
associated with inflammatory and cancerous diseases. The stimulation with L. 
acidophilus, E. coli and Salmonella enteritis shown no influence on Cox-1/ Cox-2 ration 
(Nurmi et al. 2005). Interestingly, the metastatic gastric adenocarcinoma cell line 
NCI-N87 treated with bacteria B. lactis 420 and L. acidophilus 74-2 did not affect the 
Cox-1 or Cox-2 expression, but the cell- free supernatant of L. acidophilus 74-2 
induced a Cox-1 expression (Mahkonen et al. 2008). Thus potentially anti-
inflammatory and anti-carcinogenic properties relating to Cox-1/ Cox-2 ratio seem to 
be bacteria specific as well as depend on absence or presence of colon cancer. 
 
1.8.1.3 Streptococcus salviarius subsp. thermophilus ST21 
The non-pathogenic bacteria Streptococcus salivarius subsp. thermophilus (St. 
thermophilus) is a gram-positive, non-motile, thermophile cocci with an optimal growth 
temperature of 45°C. These bacteria are facultative anaerobe and are capable to 
generating energy in form as adenosine triphosphate (ATP) under oxygen use or 
through fermentation without oxygen. Further, St. thermophilus is oxidase negative, 
chytochrom negative as well as catalaze negative. Its property to produce lactic acid is 
commercial used as starter culture in the production of milk, cheese and other dairy 
products (GenomeProject; MicrobeWiki 2006)  
 
St. thermophilus STR21 as starter culture is used in combination with other probiotic 
bacteria. A study with 162 children of the age between 9 months and 10 years who 
had a high index of exposure to environmental microorganism, showed that there 
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were no significant differences in the rate of immunoglobulin and isoagglutinin 
acquisition among children supplemented for 4 months with low-fat milk fermented 
by St. thermophilus or low-fat milk fermented by St. thermophilus and Lactobacillus casein 
which was further added with Lactobacillus acidophilus, oligofructose and inulin after 
the fermentation process (Pérez et al. 2009). In hospital patients with an average age 
of 74 years, the supplementation twice a day with a probiotic drink containing L. 
casein, Lactobacillus bulgaris and St. thermophilus led to a reduced incidence of antibiotic 
or Clostridium difficile associated diarrhea (Hickson et al. 2007). The mixture of St. 
thermophilus, L. acidophilus and Bifidobacterium animalis subsp. lactis (YO-MIXTM Y109 
FRO 1000) led to a strong TNF-α gene expression and to a moderate reduction of IL-
6 mRNA level in the colon of Wistar rats suggesting a pro-inflammatory reaction. In 
Wistar rats with Trinitroenzenesulfonic acid (TNBS)-induced colitis were observed a 
strong augmentation of TNF-α and IL-6 which could explicit reduced through the 
supplementation of the probiotic mix (Amit-Romach et al. 2010).   
A study in human peripheral blood mononuclear cells (PMBC) researched the affect of 
St. thermophilus THS alone or in combination with Bifidobacterium longum 1/10, 
Bifidobacterium breve Bb99 and Bifidobacterium animalis subsp. lactis Bb12 or non-
pathogenic Escherichia coli DH5α to the production of TNFα, IL-12, IFN-γ and IL-10. 
The cytokine production was dose- as well as time-dependent. St. thermophilus THS 
alone induced a strong TNF-α procution, a sign of inflammatory response. In 
combination with B. longum 1/10 was observed a higher TNF-α production, whereas 
together with B. breve Bb99 and B. lactis Bb12 did not alter this level.  Other St. 
thermophilus THS alone increased explicit the IL-12 as well as IFN-γ concentration, 
whereas the combination with the three other probiotic bacteria resulted in a 
suppression of St. thermuphilus THS-induced IL-12 and IFN-γ production. No 
significant influence of IL-10 concentration was found for St. thermophilus THS alone. 
But the combination of B. longum 1/10 and B. breve Bb99 led to a slight augmentation 
of IL-10. St. thermophilus THS in combination with E. coli DH5α showed a higher 
TNF-α and IL-10 level compare with E. coli DH5α-induced stimulation. No 
alternation was observed for this combination on IL-12 and IFN-γ production 
(Kekkonen et al. 2008). In contrast, in 6 weeks of age old BALB/c mice feeding with  
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St. thermophilus CRL 412 led to a strong augmentation of IFN-γ and IL-4 
concentration after day 2, 5 and 7. No affect was observed of the production of TNF-
α, IL-12, IL-2 and IL-10 at all three times. Moreover, St. thermophilus CRL 412 did 
not impair the Th1/Th2 balance and did not change the Bcl2 protein level (Perdigón 
et al. 2002). Cell debris of Streptococcus thermopilus MB455 did not affect the IL-8 
production in HT-29/19A cells, but extract fraction of this strain increased the IL-8 
level at a concentration of 107 to 1010 cfu/ml (Lammers et al. 2002). 
These data suggest the immunoregulated effect of St. thermophilus is strain-dependent 
as well as is affected by the presence of other bacteria and further depend on the 
researched model. 
 
1.8.2 Control bacteria 
1.8.2.1 Eubacterium biformeT 
Eubacterium biformeT is an obligatory anaerobic, gram-positive and non-motile 
bacterium occurring in rods and coccoid from in pairs or chains. The optimal growth 
temperature is 37°C, but some strains are able to grow at 45°C. E. biformeT ferments 
PY-glucose-Tween 80 into DL-lactic acid and butyric acid as well as into moderate 
amounts of ethanol and occasionally succinice, pyruvic and acetic acid. The 
fermentation of PY-pyruvate-Tween 80 results in butyrate as well as lactate and 
acetate production. E. biformeT is a normal inhabit of the human intestinal tract (v. 
Holdeman and Moore 1974). 
 
1.8.2.2 Escherichia coliTC XL blue 
Escherichia coli is a gram negative rod-shaped bacterium which is able to grow under 
facultative anaerobic conditions at an optimal temperature of about 37°C. Under 
anaerobic atmosphere E. coli used mixed-acid fermentation with the production of 
lactate, succinate and acetate. The harmless strains of E. coli inhabit the lower 
intestine in humans as well as animals. As a part of the normal microbiota E. coli has 
the function to promote the host against the establishment of pathogenic bacteria. E. 
coli is also able to produce vitamin K2 (MicrobeWiki 2008). The E. coli strain XL blue 
is characterized through its nalidixic acid and tetracycline resistant (OpenWetWare). 
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An experiment comparing the effect of gram-positive and gram-negative bacteria in 
non-polarized Caco-2 cells, showed E. coli strains led to a strong increase of IL-8 
concentration in a strain-dependent manner. E. coli Nissle resulted in a lower 
augmentation than the E. coli strains F 18, BJ4, MG1655 and UTI. Interestingly, live 
E. coli strains have a stronger affect than UV- killed E. coli strains. Moreover, E. coli 
strains led to a higher rise of IL-8 production as Bifidobacterium ssp. or Lactobacilus 
ssp. A similar effect was observed for the TGF-β1 production. And only the gram-
negative E. coli strains induced a semimaturation of dendritic cells which underlied 
Caco-2 cell layer in a TLR-4-dependent manner (Zeuthen et al. 2010). 
The non-pathogenic E. coli strain K12 reduced the concentration of IL-8, IL-6, TNF-
α, IL-1β after apical stimulation of Caco-2 cells in the basolateral presence of 
leucocytes compared to the direct treatment of bacteria on leucocytes.  The apical 
addition of bacteria to the Caco-2 cells especially augmented the IL-8 and IL-6 
concentration, but the measured concentrations were far below those observing after 
apical bacteria stimulation of Caco-2 cell layer in the basolateral presence of 
leucocytes.  The IL-8 mRNA expression was strong increased in Caco-2 cells by 15.4- 
fold and in leucocytes by 10.4- fold which did not attended by the observed relation of 
rose IL-8 production (Parlesak et al. 2004). The augmentation of IL-8 expression in 
Caco-2 cells after stimulation with non-pathogenic E. coli seems to be dose-dependent 
and can significantly suppressed through the presence of Lactobacillus rhamnosus GG 
and Lactobacillus casein at a concentration of 1010 to 1011cfu/ml. Butyrate at a 
concentration of 10 mM and 20 mM was also capable to inhibit the E. coli-induced IL-
8 expression. The LPS from E. coli did not affect the IL-8 mRNA level and E. coli 
flagellin led to a slight increase (Shinji et al. 2009). 
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2 OBJECTIVES 
A long-term altered expression of chemokines such as IL-8 or cytokines such as IL-17 
can be a marker for all activations but can also cause an over-reaction of the human 
immune system and can lead to chronic inflammatory bowel diseases including 
Crohn’s diseases and colitis ulcerosa or diverse immunopathologycal disorders 
(Remick 2005; Miossec et al. 2009). It is well know that the kind of diet and special 
foods or nutrients have an effect on appearance and concentration of inflammatory 
mediators and may affect the symptoms of diseases on a beneficial but also on a 
negative way. As such special food probiotic bacteria are discussed.  
In many cell culture or animal studies were demonstrated that IL-8 gene expression 
and IL-8 protein release are mediated by a variety of commensal and pathogenic 
bacteria (Hörmannsperger and Haller 2010). During the last years the role of IL-17 
get more and more clear and it seems that IL-17 plays also a crucial role in the 
inflammatory regulation (Miossec et al. 2009). 
 
The aim of this diploma thesis was to investigate the influence of probiotic bacteria on 
the inflammatory mediator IL-8 and IL-17 as well as their affect on caspase-3 
mediated apoptosis. IL-8 ELISA and gene expression of IL-8, IL-17 and CASP3 was 
analyzed in Caco-2 cells after the treatment with probiotic bacteria and commensal 
gut bacteria. The Caco-2 cell line was chosen as a model for the human gut because of 
its similar properties to mature enterocytes (Sambuy et al. 2005).  
This study is the first step in the work group of Uni-Doz. Dr. Alexander G. 
Haslberger to establish Caco-2 cell experiments with bacteria and present the basic 
for future studies with the focus on the epigenetic mechanism behind the effects of 
probiotic bacteria. 
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3 MATERIALS AND METHODS 
3.1 Cell line and culture conditions 
For this experiment I used the human colon carcinoma cell line CaCo-2 culturing in 
RPMI 1640 media supplemented with 10% heat-inactivated fetal bovine serum, 4 mM 
glutamine, and 100 units each of streptomycin and penicillin, at 37°C in a humidified 
atmosphere with 5% CO2 in air. After a growth period of about 14 days there was 
added 10 ng/ml Interleukin(IL)-1β to the half part of cells. After that cells with and 
without IL-1β were treated with 0.5 ml lactic acid bacteria such as Lactobacilus 
acidophilus NCFM, Bifidobacterium animalis subsp. lactis Bt420 and Streptococcus 
salivarius subsp. thermophilus  ST21 which as grew on medium, as well as supernatant 
of this three bacteria. I also added lyophilized probiotic bacteria at a concentration of 5 
x 108 cfu/ml cell medium to the Caco-2 cells without IL-1β pre-treatment. The 
pepetting scheme is listed below.  Further, I added 0.5 ml supernatant of Escherichia 
coliTC XL blue and of the human gut bacteria Eubacterium biformeT to the Caco-2 cells. 
The incubation time averaged 48 hours. For using IL-8 ELISA culture supernatant 
fluid was stored in aliquots. Cells were washed twice with ice-cold PBS before the 
DNA and mRNA were isolated. 
 
  L. acidophilus NCFM B. animalis subsp. lactis 
Bt420 
St. salivarius subsp. 
thermophilus ST2 
concentration of 
lyophilisate 
150 billion cfu/g 170 billion cfu/g 200 billion cfu/g 
stock solution 0.1 g lyophilisate in 0.2 
ml cell medium  
 7.5 x 1010 cfu/ml 
0.1 g lyophilisate in 0.2 
ml cell medium  8.5 x 
1010 cfu/ml 
0.1 g lyophilisate in 0.2 
ml cell medium  
 1x 1011 cfu/ml 
volume bacterial 
suspension/ well to 
get 5 x 108 cfu/ml 
13 µl 12 µl 10 µl 
Table 1: pipetting scheme for lyophilized probiotic bacteria to get a final concentration at 5 x 108 cfu/ml 
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3.2 Enzyme-linked immunosorbet assay (ELISA) 
To get an overview about the IL-8 concentration after stimulation the IL-8 Eli-pair 
kit from Diaclone was implemented with the cell media. 
3.2.1 Principle of the method 
The enzyme-linked immunosorbant assay (ELISA) is a method to measure a single 
protein in each sample. For the IL-8 measurement I used a double antibody sandwich 
ELISA. Thus a 96 microtiter plate is covered with IL-8 antibody attaching to the 
bottom of a well and provides antibody capture. In a second step IL-8 standard 
dilutions and samples are added to the plate. During the incubation the IL-8 proteins 
ligate to the antibodies on the bottom of the well. After incubation detection antibody 
which is conjugate to an enzyme, is added to each well. By dint of an UV plate reader 
the different intensities of the color are detected. The standard dilutions allow the 
quantification of IL-8 in the samples (Leng et al. 2008). 
 
3.2.2 Procedure 
For this experiment the IL-8 Eli-pair kit from Diaclone was used. 
Coating 
• Per plate 50 µl of the capture antibody was diluted in 10 ml of coating 
buffer. 
• 100 µl of the solution was pipetted into each well of the plate. 
• The plate was sealed and incubated overnight at 4°C. 
• After incubation the wells were discharged and washed twice with 400 µl of 
wash buffer. 
• 250 µl of saturation buffer was added to the wells and was incubated for 2.5 
hours at room temperature. 
• In the last step the saturation buffer was discarded and the plate had to dry 
one day at room temperature. 
Sample application 
Using the standard stock solution and the standard diluent buffer to receive a 
standard curve with the following scheme: 
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standard concentration  in pg/ml volume standard volume buffer 
1 (stock solution) 2000   
2 1000 210 µl standard 1 210 µl 
3 500 210 µl standard 2 210 µl 
4 250 210 µl standard 3 210 µl 
5 125 210 µl standard 4 210 µl 
6 62.5 210 µl standard 5 210 µl 
      Table 2: IL-8 standard concentration and pipetting schema 
• 100 µl of each standard and each sample were applied to the wells in 
duplicate whereas two wells contained only standard diluent buffer as blank. 
• The plate was incubated for two hours at room temperature. 
• The detection antibody solution was made out of 100 µl biotinylated 
detection anti-IL-8 and 5 ml of biotinylated antibody diluent buffer. 
• 50 µl of the prepared solution was distributed to each well and was 
incubated for one hour at room temperature. 
• The plate was emptied and washed three times with 400 µl of wash buffer. 
Color development 
• 5 µl of horseradish peroxidase-streptavidin (HRP-streptavidin) was diluted 
in 500 µl of HRP- streptavidin diluent buffer and 150 µl of this solution was 
also diluted in 10 ml of the same buffer. 
• 100 µl of the HRP-streptavidin was dispensed to each well and incubated for 
20 minutes at room temperature. 
• For color development 100 µl of 3,3’ 5,5’- Teramethylbenzidine was added 
to each well and incubated for eight minutes to achieve a color development. 
• The color reaction was stopped by adding 100 µl of 1 molar sulfuric acid to 
the wells. 
• The absorbance was measured immediately at 450 nm. 
Analysis 
The standard curve was drawn in Microsoft Office Excel 2000 and the sample 
concentrations were calculated with the determined formula. 
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3.3 Polymerase Chain Reaction (PCR) and real-time PCR analysis 
Polymerase chain reaction (PCR) allows the detection of nucleic acid sequences in a 
complex sample through amplification in a cycle process. During the amplification a 
large number of identical copies are generated which can be analyzed. In contrast to 
the end-point PCR measurement, the real- time PCR analysis detects the specific 
DNA sequences simultaneous to amplification. This detection is provided by 
monitoring of fluorescence dyes or probes which show the amount of formed products 
during the amplification. 
 
For the PCR amplification following components are required: 
• Desoxynucleotide triphosphats (dNTPs) of the four DNA-bases adenine, 
guanine, cytosine and thymine as building blocks for the new synthesized 
DNA fragments. 
• DNA-Polymerase, an enzyme building DNA out of dNTPs. 
• Magnesium-chloride as a co-factor of the DNA-polymerase. 
• Primers, short oligonucleoitides of about 15 to 40 base pairs length flanking 
the DNA sequence or promotor region of the amplified gene with the 
function as starter signal for DNA-polymerase. It is important to design a 
primer which binds stable and specific to the target sequence and not to any 
other sequences. 
• Fluorescent reporter is required for detection and quantification of the 
formed DNA (Kubista et al. 2006). 
 
3.3.1 PCR- reaction 
The PCR- reaction is performed by a temperature cycling dividing into three steps: 
denaturation, annealing and elongation. A normal PCR analysis includes 30 to 40 
cycles. 
 
Denaturation 
At the first step the double helical DNA is denaturized (melted) at a high temperature 
between 90°C and 95°C. The used temperature and duration are depending on the 
length of target DNA as well as on the instrument and used reaction components. 
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Annealing 
In the second step the primer binds to the target DNA whereas the annealing 
temperature depends on the used primer and its melting temperature. In general, the 
annealing temperature is between 50°C and 70°C. 
 
Elongation 
The Elongation takes place at a temperature about 72°C because this is the optimal 
temperature for the polymerase binding to the primer and start the DNA strands 
forming (Kubista et al. 2006). 
 
3.3.2 Real-time PCR detection system 
For the detection of amplified DNA during the cycles a fluorescent reporter is needed 
which binds to the target DNA product. Used reporters are fluorescence dyes like 
SYBR Green I, or probes such as Taqman. They show no fluorescence when they are 
free, but become a brightly fluorescence after binding to DNA. The fluorescence 
signal relates with the amount of formed double stranded products. During the initial 
cycles the signal is low and do not differ from the background signals. After achieving 
the threshold the signal increase exponentially till the saturated level is reached. At 
this point the reaction products stagnate cause of a running out of some crucial 
reaction components (Kubista et al. 2006). 
 
 
3.4 Gene expression 
3.4.1 Principle of the method 
Measurement the gene expression means the measurement of messenger RNA 
(mRNA), a product of DNA transcription which is directly proportional to the gene 
activity. But before using the PCR the mRNA have to be converted into more stable 
complementary DNA (cDNA) by reverse transcription. Three primering strategies 
base on anchored-oligo (dT) primer, random hexamer primer and sequence specific 
primer are used for reverse transcription. 
• Anchored-oligo(dT) primer which consists only thymine and binds to the 
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poly-A tail of mRNAs. 
• Random hexamer primer is a small primer of six base pairs length and binds 
randomly to all mRNAs existing within the sample. 
• Sequence specific primer binds only to specific genes sequences or part of 
their sequences (Kubista et al. 2006). 
 
3.4.2 Procedure 
3.4.2.1 Genomic mRNA isolation 
For the mRNA extraction the NucleoSpin RNA II from Macherey-Nagel was used 
and followed the instruction applied. 
 
3.4.2.2 Reverse transcription 
To convert the mRNA into cDNA the Transcriptor First Strand cDNA Synthesis Kit 
(Roche Diagnostics) was used. 
For each sample agents were mixed as following:  
transcriptor reverse transcriptase reaction buffer 4.0 µl 
deoxynucleotide mix 2.0 µl 
protector RNase inhibitor 0.5 µl 
anchored-oligo(dT) primer 1.0 µl 
transcriptor reverse transcriptase 0.5 µl 
water 6.0 µl 
RNA 6.0 µl 
total volume 20.0 µl 
Table 3: reaction mix for reverse transcriptase  
• The mixes were set at 50°C for 60 minutes for transcription.  
• The samples were heated up to 85°C for 5 minutes to inactivate the 
transcriptase.                
             
3.4.2.3 Real-time PCR 
The primers, sample composition, and cycling conditions for the IL-8, IL-17 and 
CASP3 gene expression detection are listed in the tables below. 
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Primer Sequence 
annealing 
temperature concentration 
IL-8 sense ATG ACT TCC AAG CTG GCC GTG GCT 66 °C 1.5 pmol/µl 
IL-8 antisense TCT CAG CCC TCT TCA AAA ACT TCT C 66°C 1.5 pmol/µl 
      
IL-17 sense ACT TCC ACC GCA ATG AGG AC 67°C 2.5 pmol/ µl 
Il-17 antisense GTG GAC AAT CGG GGT GAC AC 67°C 2.5 pmol/ µl 
      
CASP3 sense AGG GGA TCG TTG TAG AAG TCT 67°C 5.0 pmol/ µl 
CASP3 antisense GCC AAG AAT AAT AAC CAG GTG CT 67°C 5.0 pmol/ µl 
Table 4: Primer sequence, annealing temperature and primer concentration for the gene expression 
 
Sample composition: 
  IL-8 IL-17 CASP3 
SensiMix 5.0 µl 5.0 µl 5.0 µl 
water 2.6 µl 2.8 µl 2.8 µl 
primer 1.0 µl 1.0 µl 1.0 µl 
Sybr Green 0.2 µl 0.2 µl 0.2 µl 
4 mM MgCl2 0.2µl --- --- 
total volume 10 µl 
                                                    Table 5: reaction mix for real-time PCR 
 
PCR cycling conditions: 
  IL-8 IL-17 CASP3 
polymerase activation 10 min at 95°C 
cycling 40 times 45 times 40 times 
denaturation 30 sec 95°C 30 sec 95°C 30 sec 95°C 
annealing 40 sec 66°C 40 sec 67°C 40 sec 67°C 
elongation 30 sec 72°C 30 sec 72°C 30 sec 72°C 
melt curve 0,5°C every 5 sec from 50°C to 90°C 
Table 6: PCR cycling condition for gene expression 
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Figure 3: Real-time PCR curve of gene expression reaction 
 
3.5 Data and Statistical analysis 
The results of the real-time PCR were analyzed with the software Rotor-Gene 
Version 6.1 belonging to the Corbett Rotor Gene 3000 real time cycler. Hypothetic 
concentrations were calculated by the software and the amplification efficiency was 
adjusted between individual samples.  The gene expression of IL-8, IL-17 and CASP3 
are normalized to our reference gene Glyceraldehyde-3-phosp (GAPDH). Average 
and the standard deviations were calculated with Microsoft Office Excel 2000. A two 
tails t-test was used to determine the significance of the results which also was 
performed in Microsoft Office Excel 2000. Results were regarded as significantly 
different at P< 0.05. 
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4 RESULTS 
4.1 IL-8 ELISA 
 
 
Figure 4: IL-8 concentration in cell medium of Caco-2 cells after treatment with bacteria und bacterial supernatant 
as well as LPS from E. coli O26:B6 
 
A strong reduction of IL-8 concentration was observed after treatment with the 
bacteria Lactobacillus acidophilus NCFM by 0.22 ± 0.01 (P< 0.0001), Bifidobacterium 
animalis subsp. lactis Bt420 by 0.15 ± 0.01 (P< 0.0001) and Streptococcus salivarius 
subsp. thermophilus ST21 by 0.15 ± 0.03 (P< 0.001). Further, the supernatants of 
Escherichia coliTC XL blue and St. thermophilus ST21 also inhibited the IL-8 production 
by 0.48 and 0.89 ± 0.06 (P< 0.05). No significant affect had the supernatants of L. 
acidophilus NCFM (1.08 ± 0.05), B. lactis Bt420 (1.01 ± 0.04) and Eubacterium 
biformeT (1.09). The addition of LPS from E. coli O26:B6 to Caco-2 cells did not 
influence the IL-8 level (1.11 ± 0.13) (figure 4). 
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Figure 5: IL-8 production in IL-1β pre-treated Caco-2 cells after stimulation with bacteria and bacterial 
supernatant 
 
Figure 5 shows the results of IL-8 ELISA in IL-1β pre-treated Caco-2 cells. All three 
bacteria and their supernatants slight increased significant the IL-8 concentration 
after IL-1β pre-treatment. Numerical an augmentation was shown for bacteria L. 
acidophilus NCFM by 1.53-fold ± 0.12 (P< 0.01), B. lactis Bt420 by 1.30-fold ± 0.07 
(P< 0.001) and St. thermophilus ST21 by 1.42-fold ± 0.05 (P< 0.001). The supernatants 
of L. acidophilus NCFM, B. lactis Bt420 and St. thermophilus ST21 induced an IL-8 
production by 1.73-fold ± 0.02 (P< 0.0001), 1.42-fold ± 0.11 (P< 0.01) and 1.57-fold ± 
0.05 (P< 0.0001). No significant effect was observed for the supernatant of E. biformeT 
(1.01 ± 0.05). 
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4.2 IL-8 gene expression 
 
Figure 6: IL-8 gene expression in Caco-2 cells after stimulation with probiotic bacteria and lyophilisate of probiotic 
bacteria 
 
The results for the IL-8 gene expression after treatment with probiotic bacteria and 
the lyophilisate of them are listed in figure 6. All bacteria grown in medium led to an 
increased IL-8 gene expression. The strongest affect was observed for L. acidophilus 
NCFM by 2.53-fold ± 0.24 (P< 0.001), followed by St. thermophilus ST21 with a rise 
of 2.31-fold and B. lactis Bt420 with 1.65 ± 0.18 (P< 0.001). In contrast the lyophilized 
bacteria St. thermophilus ST21 reduced the IL-8 mRNA level by 0.20-fold ± 0.04 (P< 
0.0001) and B. lactis Bt420 by 0.49-fold ± 0.03 (P< 0.0001). Lyophilized L. acidophilus 
NCFM did not alter the IL-8 gene expression (0.98 ± 0.11). 
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Figure 7: IL-8 expression in Caco-2 cells after stimulation with bacterial supernatant 
 
In contrast to the treatment of bacteria, the stimulation with the supernatants of the 
bacteria resulted in a down-regulation of IL-8 gene expression in case of L. acidophilus 
NCFM by 0.13-fold, B. lactis Bt420 by 0.82-fold, St. thermophilus ST21 by 0.31-fold 
± 0.03 (P< 0.0001) and E. coli XL blue by 0.28-fold ± 0.05 (P< 0.0001). The 
supernatant of E. biformeT had no significant affect on IL-8 mRNA level (1.10 ± 0.18). 
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4.3 IL-17 gene expression 
 
Figure 8: IL-17 gene expression in Caco-2 cells after stimulation with probiotic bacteria and lyophilized probiotic 
bacteria 
 
A slow significant augmentation of IL-17 gene expression was seen for L. acidophilus 
NCFM by 1.42-fold ± 0.20 (P< 0.01). To a reduction of IL-17 mRNA level led B. 
lactis Bt420 by 0.48-fold ± 0.02 (P< 0.01). No significant influence had the stimulation 
with St. thermophilus ST21 (1.23 ± 0.22). All lyophilized probiotic bacteria induced a 
strong up-regulation of IL-17 gene expression. The strongest effect was observed for 
the lyophilisate of St. thermophilus St21 by 15.30-fold ± 0.51, followed by lyophilized L. 
acidophilus NCFM (8.47 ± 1.48) and lyophilized B. lactis Bt420 (4.27 ± 0.42). 
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Figure 9: IL-17 gene expression in Caco-2 cells after stimulation with bacterial supernatant 
 
Only the supernatant of E. biformeT led to a significant augmentation of IL-17 gene 
expression by 2.00-fold ± 0.13 (P< 0.0001). The other supernatants did not alter the 
IL-17 gene expression (L. acidophilus NCFM by 0.87± 0.25, B. lactis Bt420 by 1.23 ± 
0.17, St. thermophilus ST21 by 0.95 and E. coli XL blue by 1.06). 
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4.4 CASP3 gene expression 
 
Figure 10: CASP3 gene expression in Caco-2 cells after stimulation with lyophilized probiotic bacteria 
 
The lyophilized probiotic bacteria St. thermophilus ST21 inhibited the CASP3 gene 
expression by 0.46 ± 0.01 (P< 0.001) and B. lactis Bt420 led to an Il-17 mRNA level 
reduction by 0.63 ± 0.14 (P< 0.01). No significant alternation was observed for the 
treatment with the lyophilisate of L. acidophilus NCFM (1.08 ± 0.05). 
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Figure 11: IL-17 gene expression in Caco-2 cells after treatment with supernatant of bacteria 
 
An explicit reduction of CASP3 gene expression was showed for the treatment with 
supernatant of L. acidophilus NCFM by 0.05-fold ± 0.01 (P< 0.0001). A slight, but 
significant decrease was resulted after the stimulation with the supernatants of B. 
lactis Bt420 by 0.82-fold ± 0.03 (P< 0.0001), St. thermophilus ST21 by 0.81-fold ± 0.07 
(P< 0.001), E. coli XL blue by 0.85-fold ± 0.08 (P< 0.01) and E. biformeT by 0.77-fold ± 
0.08 (P< 0.001). 
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5 DISCUSSION 
5.1 Probiotic bacteria 
5.1.1 Lactobacillus acidophilus NCFM 
The Lactobacillus acidophilus strain NCFM is well known and is used in dairy 
products and other fermented products since about 30 years. Its beneficial effects on 
humans health includes exclusion of pathogenic bacteria, reduction of the incidence of 
pediatric diarrhea, lower the concentration of toxic amines in blood of dialysis patients 
with small bowel bacterial overgrowth and decrease of cholesterol level. An adequate 
daily intake of L. acidophilus NCFM may facilitates the lactose digestion in lactose-
intolerant individuals (Sanders and Klaenhammer 2001). In children at the age of 3 to 
5 years L. acidophilus NCFM alone or in combination with Bifidobacterium animalis 
subsp. lactis Bi-07 reduce explicit the incidence of fever, cough and rhinorrhea as well 
as the duration of illness and the use of antibiotics during the six winter months. In 
few studies it could be shown that L. acidophilus NCFM induces a production of pro- 
and anti-inflammatory cytokines such as IL-6 and IL-8 or IL-10 in the intestinal 
epithelial cells as well as dendritic cells (Konstantinov et al. 2008; Zeuthen et al. 2010). 
Many data suggest a protective role of probiotics in case of bacteria-induced infection. 
It could be shown that a pre-treatment with (potential) probiotic bacteria inhibit a 
pro-inflammatory response (Nemeth et al. 2006; Roselli et al. 2006; Lopez et al. 2008; 
Nandakumar et al. 2009).  
I have found similar results in my experiments. As inflammatory marker used the 
chemotractic cytokine Interleukin(IL)-8 which is released in response to microbial 
stimulation and in the presence of pro-inflammatory cytokines such as tumor necrosis 
factor (TNF) and IL-1. This chemokine is a good inflammatory marker because IL-8 
occurs in the early state of an inflammation and cause of its longevity at site of acute 
inflammation. Further, IL-8 plays a crucial role in the neutrophli recruitment and 
regulation of inflammatory response in general (Baggiolini et al. 1995; Remick 2005).  
The addition of L. acidophilus NCFM grown in medium to Caco-2 cells led to a 
strong reduction of the pro-inflammatory cheomokine IL-8 by 0.22-fold ± 0.01 (P< 
0.0001). Whereas the pre-stimulation with the pro-inflammatory cytokine IL-1β 
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followed by L. acidophilus NCFM apply resulted in a slight increase of IL-8 
production by 1.53-fold ± 0.12 (P< 0.01) compared to the IL-1β-induced IL-8 
production. That indicates L. acidophilus NCFM has no anti-inflammatory effect 
after an induced pro-inflammatory reaction. This finding is contrary to the published 
results of Candela who could observe a suppressive effect of L. acidophilus in case of 
IL-1β-induced IL-8 production (Candela et al. 2008). Perhaps the modulation of IL-
1β-induced IL-8 secretion is strain-specific. Interestingly, the IL-8 gene expression 
was up-regulated by 2.53-fold ± 0.24 (P< 0.001). Therewith the IL-8 gene activity is 
in contrast to the measured IL-8 protein concentration suggesting L. acidophilus 
NCFM itself induces a pro-inflammatory response at transcriptional level, but there 
might be also other regulatory mechanisms which blocked the pro-inflammatory 
cascade within Caco-2 cells. The work group of Wang et al have observed the same 
phenomenon for the bacteria species Enterococcus feacalis (EC1, EC3, EC15, EC16), 
Lactobacillus rhamnosus GG and Lactobacillus bulgaris D1 in Caco-2 cells (Wang et al. 
2008). In TNF-α pre-treated HT-29 cell line was also found an increased IL-8 mRNA 
level, but a lower extracellular IL-8 concentration after addition of Lactobacillus 
plantarum 299v (McCracken et al. 2002). 
There are two regulation mechanisms which could explain this observation - either a 
post-transcriptional or a post-translational regulatory mechanism. The post-
transcriptional regulons coordinate the mRNA stability and the translation of mRNA 
into proteins.  The most post-transcriptional control mechanisms interact with the 3’ 
untranslated region (UTR) of mRNA to block the protein synthesis because UTRs 
encoding often proteins which are able to induce mRNA degradation and/ or 
translation inhibition. Such mechanisms targeting either the mRNA translation 
initiation process or lead to a selectively inhibition of the translation of capped mRNA 
as well as to a reduction of recruited 60S ribosomal subunits and other RNA-
independent factors. For instance, Interferon-γ-activated inhibitor of translation 
(GAIT) complex binds to GAIT elements which are located in 3’ UTRs of a selected 
mRNA group encoding inflammatory mediators. After binding to GAIT elements, the 
GAIT complex influences components of the translation initiation pathway to block 
the protein synthesis. Other examples are the transcriptional co-activator SRC3 
increasing the activity of several transcription factors involving in the inflammatory 
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response, and diverse zinc proteins or miRNA. Interestingly, mediators involving in 
mRNA degradation or inhibition of mRNA translation, are capable to repress rapidly 
the protein expression despite an on-going gene transcription (Anderson 2010). In 
addition to the post-transcriptional mechanisms, the post-translation regulation is 
also a crucial step in the secretion or storage as well as degradation of produced 
proteins. The synthesized chemokines contain a single peptide that mediates the 
chemokines transport into the secretory apparatus of the cell. Chemokines of the 
membrane-bound chemokines family are released after the proteloytic cleavage by 
proteases of ADAM family. The release of chemokines is limited by diverse complex 
interactions with extracellular as well as cell surface components. But chemokines can 
be also stored within the cells to mediate a more rapidly secretion on a further cell 
activation. It seems that IL-8 storage has the function as endothelial cell memory on 
inflammatory stimulation (Comerforda and Nibbs 2005). 
Hörmannsperger et al have demonstrated in an experiment that L. casein did not 
impair the TNF-induced interferon-inducible protein (IP-) 10 promotor activity and 
gene expression of IP-10 mRNA, a pro-inflammatory T cell chemokine, but it blocked 
the IP-10 protein secretion as well as IP-10 mediated T cell transmigration. The anti-
inflammatory effect was caused by a heat-labile L. casein cell surface protein which did 
not alter the IP-10 protein production, but it led to a lower level of intracellular IP-
protein stability blocking the IP-10 secretion. The blocking of IP-10 secretion 
through brefeldin A resulted in a degradation of IP-10 instead of intracellular 
accumulation. Moreover, L. casein-induced ubiquitination of IP-10 regulated the 
degradation of chemokines without affect to the proteins for proteasomal and 
lysosomal degradation. Further, the L. casein surface protein had properties as 3-
methyladenine (3-MA) leading to an inhibition of vesicular trafficking of IP-10 and its 
intracellular degradation. This affect was not observed for IL-6. That suggests 
probiotic bacteria are able to mediate post-transcriptional or post-translational 
regulation mechanisms in intestinal epithelial cells and have so an anti-inflammatory 
effect (Hörmannsperger et al. 2009).  
In contrast to the bacteria grown in medium, the lyophilized L. acidophilus NCFM 
did not alter the IL-8 gene expression (0.98 ± 0.11). The reason for this observation 
could be different medium growth conditions and different metabolism as well as 
metabolites. These findings suggest that the IL-8 response in Caco-2 cells depends on 
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the condition in which bacteria are applied. 
The supernatant of L. acidophilus NCFM showed a strong reduction of IL-8 mRNA 
by 0.13-fold without a significant alternation of IL-8 protein concentration suggesting 
cell wall components of L. acidophilus NCFM induced another inflammatory 
response than its metabolites. The discrepancy between IL-8 mRNA level and 
secreted IL-8 also indicates the involvement of post-transcriptional or post-
translation mechanisms. 
As the second inflammatory indicator I used the pro-inflammatory cytokine 
Interleukin (IL)-17. It is released major by Th17 cells and occurs in the late state of 
inflammatory response. The target cell type of IL-17 is neutrophil. IL-17 secretion is 
associated with chronic inflammation and serve immunopathologic conditions (Zaph et 
al. 2008). As far as I know there are no studies which have focused on IL-17 gene 
expression in enterocytes. L. acidophilus NCFM induced a slight augmentation of 
IL-17 gene expression by 1.42-fold ± 0.20 (P< 0.01) and lyophilisate of L. acidophilus 
NCFM increased it even by 8.47 ± 1.48. Whereas the supernatant of L. acidophilus 
NCFM did not alter significant the IL-17 mRNA level (0.87± 0.25) suggesting the 
metabolites of L. acidophilus NCFM did not induce a response in enterocytes. In 
contrast to that the presence of the bacteria activates an inflammatory response at the 
transcriptional level. My data indicates that L. acidophilus NCFM grown in medium 
as well as lyophilized L. acidophilus NCFM induce an augmentation of IL-17 gene 
expression, but I’m not able to describe the scale of this effect because in non-treated 
Caco-2 cells the IL-17 gene expression was to small (a gently inclined of cycle curve 
compare to the others) to use it as a “good” control value. Further, I did not measure 
the IL-17 protein concentration thus I am not able to say if this increase mRNA level 
is also reflected in the IL-17 extracellular protein level or if even IL-17 is released by 
enterocytes such as Caco-2 cells. But in murine splenocytes treated with TGF-β plus 
IL-6 were shown a drastic increase of IL-17 production and a lower IL-27 
concentration. The addition of heat-killed Lactobacillus acidophilus and Lactobacillus 
bulgaris induced a slight IL-17 production and a reduction of IL-27 (Tanabe et al. 
2008) indicating L. acidophilus induced a IL-17 production which attendant with a 
higher IL-17 mRNA level. It is published that commensal bacteria have a suppressive 
effect of IL-17 concentration in larger intestine, but no influence of Lactobacillus 
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species was found in lamina propria of small intestine (Dogi et al. 2008). Thus the 
immunomodulation properties of L. acidophilus  in connection with IL-17 seem to be 
depends on location of stimulation.  
To see if the used probiotic bacteria have a cytotoxic effect to the Caco-2 cells, I 
analyzed the CASP3 gene expression. Caspase3, a proteolytic enzyme, is a member of 
the executioner caspases leading directly to apoptosis, the programmed cell death. 
Because caspase 3 is activated through both, the extrinsic as well as intrinsic pathway, 
it is a good marker for induced cell death. The regulation of apoptosis is essential for 
the maintenance of cell integrity and intestinal epithelial cell function (Perl et al. 
2005). The lyophilisate of L. acidophilus NCFM did not change the CASP3 gene 
activity (1.08 ± 0.05). I found only an explicit reduction of CASP3 gene expression in 
the case of supernatant of L. acidophilus NCFM by 0.05-fold ± 0.01 (P< 0.0001) 
indicating metabolites of L. acidophilus NCFM are capable to induce an anti-
apoptotic effect in Caco-2 cells. In the case of Lactobacillus rhamnosus GG was observed 
a reduction of caspase-3 activity in Heliobacter pylori-infected Caco-2 cells (Myllyluoma 
et al. 2008) and a decrease of a chemical-induced caspase-3 cleavage as well as the 
number of epithelial apoptotic cells in the murine gut of two week-old mice (Lin et al. 
2008). This data suggests the effect to caspase-3 activity seems to be strain- 
dependent and is may induced by metabolites of the bacteria. 
 
5.1.2 Bifidobacterium animalis subsp. lactis Bt420 
Bifidobacterium animalis subsp. lactis Bt420 (B. lactis Bt420) has some beneficial effects 
for the human. On the one hand its metabolic function including producing of short 
chain fatty acids like acetate and lactate as well as the synthesis of folic acid (Nurmi et 
al. 2005) and on the other hand its anti-microbial activity against Staphylococcus aureus 
and E. coli (Klein et al. 2008).The consumption of B. lactis 420 in combination with 
other probiotic bacteria is associated with beneficial stimulation effect of cellular 
immune system (Klein et al. 2008) leading  to a lower incidence and duration of 
infection among healthy individuals (Roessler (nee Klein) et al. 2007), and to a 
reduction of serum level of triacylglyceroles (Klein et al. 2008). 
In my Caco-2 experiment the treatment with B. lactis Bt420 resulted in a drop of IL-8 
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concentration by 0.15-fold ± 0.01 (P< 0.0001) attendant with a suppression of 
inflammatory response like describes in human studies. Stimulation with IL-1β 
followed by addition of B. lactis Bt420 showed a small, but significant increase by 1.30-
fold ± 0.07 (P< 0.001) compare with Caco-2 cells treated with IL-1β alone. This 
observation suggests that a supplementation with B. lactis Bt420 during an infection 
does not have anti-inflammatory effects. Like observed for L. acidophilus NCFM, B. 
lactis Bt420 also led to an up-regulation of IL-8 mRNA expression by 1.65 ± 0.18 (P< 
0.001) which is contrary to the measured reduced IL-8 protein level. The reason for 
this observation could be post-transcriptional or post-translational mechanisms which 
are described in detail above by L. acidophilus NCFM. Because B. lactis Bt420 led to 
a slighter increased IL-8mRNA expression as well as IL-8 production after IL-1β pre-
treatment, it could be suggest that B. lactis Bt420 induced a slighter pro-inflammatory 
response compare to L. acidophilus NCFM. Interestingly, the lyophilisate of B. lactis 
Bt420 inhibited the IL-8 expression by 0.49 ± 0.03 (P< 0.0001). Thus there is 
evidence that the condition in which the bacteria are applied or the medium growth 
conditions are crucial for the induced inflammatory response in Caco-2 cells. 
The supernatant of B. lactis Bt420 showed no significant alternation of IL-8 
concentration (1.01 ± 0.04) in Caco-2 cells, but an increased IL-8 expression level by 
1.42-fold ± 0.11 (P< 0.01) in IL-1β pre-treated Caco-2 cells in addition to B. lactis 
Bt420. The similar increase of IL-8 production in IL-1β pre-treated Caco-2 cells after 
stimulation with the bacterium or its supernatant indicates that supplementation with 
live bacteria or their supernatant have the same effect in infected cells, but the 
differences of IL-8 secretion in “healthy” Caco-2 cells suggest whole bacteria with its 
cell components are required for the protective effect of B. lactis Bt420. In contrast to 
the bacterium B. lactis 420, its supernatant induced a slight reduction of IL-8 mRNA 
by 0.82-fold which does not alter the IL-8 protein concentration suggesting post-
transcriptional and/ or post-translational regulations are involved in the immune 
response. 
Further, B. lactis Bt420 is the only of my analyzed probiotic bacteria leading to a 
reduction of IL-17 gene expression by 0.48-fold ± 0.02 (P< 0.01). In contrast the 
lyophilized B. lactis Bt420 induced an IL-17 expression by 4.47 ± 0.42. That result 
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indicates a protective effect of B. lactis Bt420 in case of chronic inflammation or 
immunopathologic disorders which are mediated by IL-17. But I did not measure the 
IL-17 extracellular protein concentration, so it is unclear if the altered gene activity is 
also reflected in the protein level. Or if IL-17 is generally released by Caco-2 cells 
because as far as I know IL-17 secretion was only found in Th17 or nature killer cells 
(Zaph et al. 2008; Gaffen 2009) as well as in murine splenocytes (Tanabe et al. 2008) 
and monocytes-derived dendritic cells (López et al. 2010). In an experiment with 
TGF-β plus IL-6 treated murine splenocytes was observed a drastic increase of IL-17 
production and a lower IL-27 concentration. The addition of heat-killed 
Bifidobacterium infanits to the murine splenocytes reduced the TGF-β- and IL-6- 
induced IL-17 production and increased the IL-27 secretion. Whereas heat-killed 
Bifidobacterium bifidum led to a higher IL-17 concentration (Tanabe et al. 2008). This 
finding indicates that the affect to IL-17 production seems to be species specific. In 
case of B. lactis Bt420 it may be an IL-17 inhibitory effect. Because its supernatant did 
not significantly impair the IL-17 gene expression (1.23 ± 0.17) in Caco-2 cells 
suggesting the effect has to be mediated by bacterial cell surface components. 
The CASP3 gene expression was slighter inhibited through the supernatant of B. 
lactis Bt420 by 0.82 ± 0.03 (P< 0.001) and has thus not a cytotoxic effect. The 
stimulation with lyophilized B. lactis Bt420 also reduced the CASP3 mRNA-level by 
0.62 ± 0.14 (P< 0.01). In the case of B. lactis Bt420 I have expected an increased 
CASP3 gene expression because for Propionibacteria species were found a cleavage of 
caspase-3 activity in Caco-2 cells caused of the production of propionate and acetate 
(Jan G. 2002). B. lactis strain also produce acetate (Nurmi et al. 2005). And for B. lactis 
strain Bb12 an apoptosis-inducing effect in Caco-2 cells was observed (Altonsy et al. 
2010). But maybe B. lactis Bt420 produce acetate in to small concentration that this 
production does not affect the CASP3 gene activation. And it also produces lactate 
which may inhibit the cytotoxic effect of acetate. 
 
 
 
 
 
70 DISCUSSION 
 
5.1.3 Streptococcus salivarius subsp. thermophilus ST21 
Streptococcus salivarius subsp. thermophilus (St. thermophilus) is common used as starter 
culture in combination with other probiotic bacteria, whereas the immunomodulated 
effect is strong depends on used St. thermophilus strain as well as the combinated 
probiotics and the kind of observed model. As an example, in children no significant 
differences were observed in the rate of immunoglobulin and isoagglutinin acquisition 
among children supplemented for 4 months with low-fat milk fermented by St. 
thermophilus or low-fat milk fermented by St. thermophilus and Lactobacillus casein which 
was further added with Lactobacillus acidophilus, oligofructose and inulin after 
fermentation process (Pérez et al. 2009). But in elderly hospital patients the 
supplementation with a probiotic drink containing L. casein, Lactobacillus bulgaris and 
St. thermophilus twice a day led to reduced incidence of antibiotic or Clostridium difficile 
associated diarrhea (Hickson et al. 2007). And in Wistar rats feeding with a mixture of 
St. thermophilus, Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis (YO-
MIXTM Y109 FRO 1000) were found a strong gene expression of the pro-
inflammatory TNF-α and a moderate reduction of the IL-6 mRNA level, an anti-
inflammatory act cytokine, in the colon. In Wistar rats with Trinitroenzenesulfonic 
acid (TNBS)-induced colitis were observed a strong augmentation of TNF-α and IL-6 
which could explicit reduced through the supplementation of the probiotic mix (Amit-
Romach et al. 2010). 
For the St. thermophilus strain ST21 I could observe a decrease IL-8 concentration by 
0.15-fold ± 0.03 (P< 0.001) in Caco-2 cells and a slight increase of IL-8 production by 
1.42-fold ± 0.05 (P< 0.001) in IL-1β pre-treated Caco-2 cells. That was also found for 
the other two probiotic bacteria which indicate a preventive anti-inflammatory effect 
of the used lactic acid bacteria, but sadly no protective effect after an induced pro-
inflammatory response. 
Interestingly, like the other two probiotic bacteria St. thermophilus ST21 induced an 
up-regulation of IL-8 gene expression by 2.31-fold which is contrary to the measured 
IL-8 protein level. To explain this phenomenon also in the case of St. thremophilus 
ST21 post-transcriptional and/or post-translational mediated regulations have to be 
involved like described above by L. acidophilus NCFM. The lyophilized St. 
thermophilus ST21 blocked the IL-8 gene expression by 0.20 ± 0.04 (P< 0.0001) 
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indicating the affect to IL-8 gene expression is mediated by conditions in which the 
bacteria are grew and also on its metabolism and its metabolites. 
The supernatant of St. thermophilus ST21 is the only one of the lactic acid bacteria 
supernatants leading to a lower concentration  of IL-8 by 0.89-fold ± 0.06 (P< 0.05) in 
Caco-2 cells. An increase by 1.57-fold ± 0.05 (P< 0.0001) was measured in IL-1β pre-
treated Caco-2 cells in addition to St. thermophilus ST21 supernatant suggesting a 
small preventive anti-inflammatory effect of St. thermophilus ST21 supernatant, but 
without a protection effect in Caco-2 cells with an induced inflammatory cascade. The 
IL-8 mRNA expression was explicit blocked by 0.31-fold ± 0.03 (P< 0.0001) after 
stimulation with supernatant of St. thermophiuls and is reflected in a slight reduced IL-
8 secretion. The IL-17 gene expression was not affected by the treatment with St. 
thermophilus ST21 and its supernatant (1.23 ± 0.22 and 1.23 ± 0.17). Whereas 
lyophilized St. thermophilus ST21 induced a strong augmentation by 15.30 ± 0.51. This 
observation indicates that the affect of St. thermophilus St21 on IL-17 response is 
modulated by the condition in which the bacteria are applied and thus by different 
metabolites. 
A slight suppression of CASP3 expression was observed for the supernatant of St. 
thermophilus ST21 by 0.81-fold ± 0.07 (P< 0.001) which is conform with the finding 
that St. thermophilus CRL 412 did not changed the Bcl2 family level (Perdigón et al. 
2002) which are involved in the activation of apoptosis cascade. So St. thermophilus 
ST21 only induced an IL-8 response and seems to be tolerates by Caco-2 cells. The 
lyophilisate of St. thermophilus St21 inhibited the CASP3 activity by 0.46 ± 0.01 (P< 
0.001) suggesting St. thermophilus ST21 and/ or its cell components lead to a stronger 
reduction of CASP-3 gene expression and thus stimulate the cell growth. 
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5.2 Control bacteria 
5.2.1 Eubacterium biforme T 
We used the supernatant of the common gut bacteria Eubacterium biformeT as a 
reference to compare the effect of probiotic bacteria to a commensal bacterium. 
Like the supernatants of L. acidophilus NCFM and B. lactis Bt420, the supernatant of 
E. biformeT also did not affect the IL-8 concentration in Caco-2 cells (1.09). Further, 
the supernatant of E. biformeT was the only one which did not alter the IL-8 
production (1.01 ± 0.05) in IL-1β pre-treated Caco-2 cells indicating commensal 
bacteria did not mediate am immune response even in the case of inflammatory 
response. The observation in IL-8 production are conform to the measured IL-8 gene 
expression which is not significantly changed after stimulation with E. biformeT 
supernatant (1.10 ± 0.18). Intestinally, only the supernatant of E. biformeT led to a 
strong augmentation of IL-17 gene expression by 2.00-fold ± 0.13 (P< 0.0001), but I 
do not know if the increased IL-17 mRNA level convert also to protein level because I 
did not analyzed the extracellular IL-17 concentration. Whatever, this finding is quite 
interesting because the commensal bacterium E. biformeT did not alter neither IL-8 
gene expression nor IL-8 protein concentration in normal as well as IL-1β pre-treated 
Caco-2 cells. Thus any metabolites of E. biformeT are capable to induce a chronic 
inflammatory reaction through IL-17 gene expression. Perhaps the metabolite 
butyrate which is major produced by E. biformeT, is the reason for this observation 
because butyrate alone induced an augmentation of IL-17 expression by 3.72- fold ± 
1.23 in Caco-2 cells (Annex 3). 
A similar inhibitor effect was found for the supernatant of E. biformeT to the CASP3 
gene expression by 0.77-fold ± 0.08 (P< 0.001) compare to the supernatants of B. lactis 
Bt420, St. thermophilus ST21 and E. coli XL blue which is a sign that probiotic or 
commensal bacteria have no harmful effects on cell integrity and its function. A main 
reason for this finding could be that this bacteria major produce butyrate and lactate 
which do not induce a caspase activation in contrast to propionate and acetate (Jan et 
al. 2002). In contrast to the published results I could found that the addition of 
butyrate induced to a rise of CASP-3 mRNA level by 1.88 ± 0.07. But I only analyzed 
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the gene activity so I am not able to describe if there is an effect to the protein level. 
 
5.2.2 Escherichia coliTC XL blue  
The harmless species of the gram-negative bacteria Escherichia coli are common 
inhabitants in the human gastrointestinal tract. In Caco-2 cells E. coli strains led to a 
strong augmentation of IL-8 concentration. Whereas the strain E. coli Nissle induced 
to a lower rise than the E. coli strains F 18, BJ4, MG1655 and UTI. Further, E. coli 
strains led to a higher rise of IL-8 production as Bifidobacteria ssp. or Lactobacilli ssp. 
A similar effect was observed for the TGF-β production (Zeuthen et al. 2008). The 
non-pathogenic E. coli strain K12 reduced the concentration of IL-8, IL-6, TNF-α, IL-
1β after apical stimulation of Caco-2 cells in the basolateral presence of leucocytes 
compared to the direct treatment of bacteria on leucocytes. The apical addition of 
bacteria to the Caco-2 cell especially augmented the IL-8 and IL-6 concentration, but 
the measured concentration were far below those observing after apical bacteria 
stimulation of Caco-2 cell layer in the basolateral presence of leucocytes. The IL-8 
mRNA expression was strong increased in Caco-2 cells by 15.4- fold and in leucocytes 
by 10.4- fold (Parlesak et al. 2004). The augmentation of IL-8 expression in Caco-2 
cells after stimulation with non-pathogenic E. coli is dose-dependent and can 
significantly suppressed by Lactobacillus rhamnosus GG and Lactobacillus casein at a 
concentration of 1010 to 1011 cfu/ml. Butyrate at a concentration of 10 mM and 20 
mM was also capable to inhibit the E. coli-induced IL-8 expression (Shinji et al. 2009).  
In contrast to the published results of E. coli, I found a drop of IL-8 concentration by 
0.48-fold in Caco-2 cells after stimulation with supernatant of E. coli XL blue 
indicating supernatants of E. coli may have another affect on immune regulation than 
bacteria of E. coli. Unfortunately I could only use the supernatant of E. coli and not the 
bacteria itself for this experiment. Thus I am not able to compare the affect of E. coli 
XL blue bacteria or its supernatant to IL-8 production in Caco-2 cells. But 
supernatant of E. coli XL blue also reduced the IL-8 gene expression by 0.28-fold ± 
0.05 (P< 0.0001) suggesting E. coli XL blue induce an alternation of gene expression 
which is reflected by extracellular IL-8 concentration. And the addition of LPS from 
E. coli O26:B6 to Caco-2 cells did not influence the IL-8 protein level (1.11 ± 0.13). 
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That is conform with the observation that LPS from E. coli did not affect the IL-8 
mRNA level (Shinji et al. 2009). Also the gene expression of IL-17 was not influenced 
by supernatant of E. coli XL blue (1.06). The treatment with E. coli XL blue led to a 
slight suppression of CASP3 expression by 0.85-fold ± 0.08 (P< 0.05).  For the non-
pathogen E. coli Nissle was observed an anti-apoptotic effect (Perl et al. 2005), whereas 
the pathogenic E. coli O157:H7 (EHEC) led to cell damages (Putaala et al. 2008) 
indicating a tolerance of Caco-2 cells against non-pathogenic E. coli. 
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6 SUMMERY/ ZUSAMMENFASSUNG 
To analyze how probiotic bacteria influence mediators of inflammatory response in 
intestinal cells I treated Caco-2 cells with the probiotic bacteria Lactobacillus 
acidophilus NCFM, Bifidobacterium animalis subsp. lactis Bt420 und Streptococcus 
salivarius subsp. thermophilus ST21 as well as their supernatants and lyophilisates. 
Some of the Caco-2 cells were pre-treated with the pro-inflammatory cytokine IL-1β. 
The impact on gene expression of Interleukin-8 (IL-8), Interleukin-17 (IL-17) and 
CASP3 was measured by Real-time RCR and was calibrated to GAPDH Expression. 
Furthermore, the influence of IL-8 production was analyzed by IL-8 ELISA. As 
control the Caco-2 cells were also treated with the supernatants of Eubacterium 
biformeT und Escherichia coli XL blue. 
 
The stimulation of Caco-2 cells with the probiotic bacteria induced an up-regulation of 
IL-8 gene expression. In case of Lactobacillus acidophilus NCFM was measured an 
augmentation by 2.53-fold ± 0.24 (P< 0.001). Bifidobacterium animalis subsp. lactis 
Bt420 and Streptococcus salivarius subsp. thermophilus ST21 induced an increase of IL-8 
mRNA level by 1.65-fold ± 0.18 (P< 0.001) and 2.31-fold. These results are in 
contrast to the strong decreased IL-8 protein concentration. For instance, L. 
acidophilus NCFM inhibited the IL-8 production by 0.22 ± 0.01 (P< 0.0001). B. lactis 
Bt420 led to a reduction of IL-8 concentration by 0.15 ± 0.01 (P< 0.0001) like St. 
thermophilus ST21 (0.15 ± 0.03, P< 0.001). That observation suggests that these three 
bacteria might induce also post-transcriptional and/or post-translational mechanisms 
which suppressed the pro-inflammatory response in Caco-2 cells. But the anti-
inflammatory effect was only observed in Caco-2 cells which were not pre-treated 
with the pro-inflammatory cytokine IL-1β. In Caco-2 cells where an inflammation was 
induced through IL-1β pretreatment, an increased IL-8 production was measured 
compare to the IL-1β stimulation. Interestingly, lyophilized B. lactis Bt420 and St. 
thermophilus ST21 decreased the IL-8 gene expression by 0.49-fold ± 0.03 (P< 0.0001) 
and by 0.20-fold ± 0.04 (P< 0.0001) which indicates that IL-8 response in Caco-2 cells 
is mediated by different metabolites and bacterial growth conditions. 
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The supernatants of L. acidophilus NCFM and B. lactis Bt420 as well as the 
supernatant of the commensal bacteria Eubacterium biformeT did not affect the IL-8 
production. But only the supernatants of B. lactis Bt420 and E. biformeT also did not 
alter the IL-8 gene expression. Interestingly, the supernatant of L. acidophilus 
NCFM inhibited the IL-8 gene expression, but that is not reflected in a reduced IL-
8 production. The treatment with St. thermophilus ST21 supernatant resulted in a 
decrease of IL-8 concentration (0.89 ± 0.06; P< 0.05) which is also shown in a lower 
IL-8 mRNA level (0.31 ± 0.03; P< 0.0001). Only the supernatant of the control 
bacteria Escherichia coli XL blue induced an explicit reduction of IL-8 production by 
0.48-fold. For the LPS from E. coli O26:B6 did not alter the IL-8 production.  Like the 
bacteria, all supernatants, with exception of the supernatant of E. biformeT, led to a 
small rise of IL-8 in IL-1β pre-treated Caco-2 cells. The finding that lactic acid 
bacteria have an anti-inflammatory effect, but not their supernatant, indicate that 
bacterial cell surface components induced this effect. This hypothesis is proved 
through the observation that butyrate, a fermentation product of these bacteria, did 
not alter the IL-8 mRNA expression (1.37 ± 0.37) as well as IL-8 concentration (1.07 
± 0.22) in Caco-2 cells (Annex1 and Annex 3). 
A suppression of IL-17 gene expression was found in the case of B. lactis Bt420 by 
0.48-fold ± 0.02 (P< 0.01). Interestingly, the lyophilized B. lactis Bt420 induced an IL-
17 up-regulation by 4.27 ± 0.42. In contrast to B. lactis Bt420, L. acidophilus NCFM  
increased the IL-17 gene expression by 1.42-fold ± 0.20 (P< 0.01). No significant 
change was found for the treatment with St. thermophilus ST21. Also the addition 
lyophilisates of L. acidophilus NCFM and St. thermophilus St21 to Caco-2 cells led to 
an increased IL-17 mRNA-level by 8.47-fold ± 1.48 and 15.30-fold ± 0.51. These data 
suggest that B. lactis Bt420 have a broader anti-inflammatory effect to Caco-2 cells 
than L. acidophilus NCFM and St. thermophilus ST21. No effect was observed for the 
supernatants, with exception the supernatant of E. biformeT, leading to an 
augmentation of IL-17 expression.  
Furthermore, only the supernatant of L. acidophilus NCFM (0.05 ± 0.01; P< 0.0001) 
and the lyophilized bacteria B. lactis Bt420 (0.63 ± 0.14; P< 0.01) and St. thermophilus 
St21 (0.46 ± 0.01; P< 0.0001) induced an explicit anti-apoptosis effect in Caco-2 cells 
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which is perhaps correlated with the observed inhibition of IL-8 gene expression.  
In conclusion probiotic bacteria such as L. acidophilus NCFM, B. lactis Bt420 and St. 
thermophilus ST21 showed a preventive anti-inflammatory effect. 
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Um den Einfluss von probiotischen Bakterien auf Entzündungsmediatoren in 
Darmzellen zu bestimmen, wurden Caco-2 Zellen mit und ohne IL-1β Vorbehandlung 
mit den probiotischen Bakterien Lactobacillus acidophilus NCFM, Bifidobacterium 
animalis subsp. lactis Bt420 und Streptococcus salivarius subsp. thermophilus ST21 sowie 
deren Überstände und Lyophilisats der Bakterien behandelt. Und deren Auswirkung 
auf die Genexpression von Interleukin-8 (IL-8), Interleukin-17 (IL-17) und CASP3 
mit Hilfe der Real-time PCR bestimmt. Außerdem wurde der Einfluss der Bakterien 
auf die IL-8 Produktion mittels ELISA gemessen. Zum Vergleich wurden die Caco-2 
Zellen mit den Überstand von Eubacterium biformeT und Escherichia coli XL blue 
behandelt. 
 
Die Behandlung von Caco-2 Zellen mit den probiotischen Bakterien Lactobacillus 
acidophilus NCFM, Bifidobacterium animalis subsp. lactis Bt420 und Streptococcus 
salivarius subsp. thermophilus ST21 führte zu einem Anstieg der IL-8 Genexpression. 
Wobei die Zugabe von Lactobacillus acidophilus NCFM einen Anstieg um das 2,53-
fache ± 0,24 (P< 0,001) zur Folge hatte. Bifidobacterium animalis subsp. lactis Bt420 
und Streptococcus salivarius subsp. thermophilus ST21 induzierten einen erhöhten IL-8 
mRNA Spiegel um das 1,65-fache ± 0.18 (P< 0,001) beziehungsweise um das 2,31-
fache. Diese Ergebnisse stehen im Widerspruch zu den verringerten IL-8 
Produktionen. Zum Beispiel hemmte  L. acidophilus NCFM die IL-8 Produktion um 
0,22 ± 0,01 (P< 0,001). Genau wie St. thermophilus ST21 (0,15 ± 0,03; P< 0,001) führte 
B. lactis Bt420 zu einer Reduktion der IL-8 Konzentration um das 0,15-fache ± 0,01 
(P< 0,0001). Diese Beobachtung deutet darauf hin, dass die verwendeten 
probiotischen Bakterien zudem einen post-transkriptionalen und/oder post-
translationalen Regelmechanismus in Gang setzen können, der die eingeleitete 
Entzündungsreaktion in den Caco-2 Zellen unterdrückt. Dieser 
entzündungshemmende Effekt war aber nur in den Caco-2 Zellen zu beobachten, die 
vorher nicht mit den entzündungsfördernden Cytokin IL-1β behandelt wurden. In 
den Caco-2 Zellen mit einer IL-1β Vorbehandlung konnte ein Anstieg der IL-8 
Konzentrationen gemessen werden. Interessanterweise bewirkte die Stimulierung der 
Caco-2 Zellen mit lyophilisierten B. lactis Bt420 und St. thermophilus St21 eine 
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Hemmung der IL-8 Genexpression um das 0,49-fache ± 0,03 (P< 0,0001) und um das 
0.20-fache ± 0,04 (P< 0,0001), was darauf schließen lässt, dass in Caco-2 Zellen die IL-
8 Antwort abhängig ist von den unterschiedlichen Stoffwechselprodukten sowie von 
den Bedingungen unter denen die Bakterien gezüchtet werden. 
Für die  Überstande von L. acidophilus NCFM und B. lactis Bt420 sowie dem 
Überstand vom Darmbakterium Eubacterium biformeT konnten keine signifikanten 
Änderungen in Bezug auf die IL-8 Produktion nach gewiesen werden. Wobei lediglich 
nur für die Überstande von B. lactis Bt420 und E. biformeT auch keine Veränderung 
der IL-8 Genexpression beobachtet werden konnte. Dagegen hemmte der Überstand 
von L. acidophilus NCFM die IL-8 Genexpression, was sich aber nicht in der IL-8 
Konzentration wieder spiegelt. Diese Beobachtung weist darauf hin, dass zwar die 
Stoffwechselprodukte von L. acidophilus NCFM im Überstand potentiell die IL-8 
Genexpression hemmen, aber es gleichzeitig post-transkriptionale und/ oder post-
translationale Mechanismen aktivieren muss, die diesen Effekt wieder aufheben. Der 
Überstand von St. thermophilus ST21 induzierte eine kleine Verringerung der IL-8 
Konzentration um das 0,89-fache ± 0,06 (P< 0.05), die sich auch in der verminderten 
IL-8 Geneaktivität (0,31 ± 0,03; P< 0,0001) wieder spiegelt. Nur der Überstand des 
von Escherichia coli XL blue, der als Kontrolle benutzt wurde,  führte zu einer 
deutlichen Reduzierung der IL-8 Produktion um das 0,48-fache. Für den LPS von E. 
coli O26:B6 konnte keine Veränderung gemessen werden. 
Wie bei den Bakterien, konnte auch für die Überstande, mit Ausnahme des 
Überstandes von E. biformeT, ein geringer Anstieg von IL-8 in IL-1β vorbehandelten 
Caco-2 Zellen beobachtet werden. Die Beobachtung, dass Milchsäurebakterien, nicht 
aber ihre Überstände, einen entzündungshemmenden Effekt haben, deutete darauf hin, 
dass Bestandteile der Zelloberflächen für diesen Effekt verantwortlich sein müssten. 
Diese Hypothese wird auch von der Tatsache unterstützt, dass Butyrat, ein 
Fermentationsprodukt der Bakterien, keinen Einfluss auf die IL-8 Genexpression und 
IL-8 Konzentration in Caco-2 Zellen hatte (siehe Annex1 und Annex 3). 
Ein hemmender Einfluss auf die IL-17 Genexpression konnte nur für das Bakterium 
B. lactis Bt420  (0,48 ± 0,02; P< 0,01) beobachtet werden. Interessanterweise 
induzierte das lyophilisierte Bakterium B. lactis Bt420 eine Stimulierung der IL-17 
Genexpression um das 4,27-fache ± 0,42. Im Gegensatz zu B. lactis Bt420 erhöhte L. 
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acidophilus NCFM  die IL-17 Genexpression um das 1,42-fache ± 0,20 (P< 0,01). 
Keine signifikante Veränderung konnte für die Stimulierung mit St. thermophilus ST21 
verzeichnet werden. Auch die Zugabe der Lyophilisate von L. acidophilus NCFM 
und St. thermophilus St21 zu den Caco-2 Zellen führte zu einen erhöhten IL-17 mRNA 
Spiegel um das 8,47-fache ± 1,48 und um das 15,30-fache ± 0,51. Diese Daten lassen 
darauf schließen, dass B. lactis Bt420 einen weit gefächerten entzündungshemmenden 
Effekt auf die Caco-2 Zellen ausübt, als die anderen beiden probiotischen Bakterien. 
Keinen Einfluss konnte für die Überstande auf die IL-17 Genaktivität verzeichnet 
werden, mit Ausnahme des Überstandes von E. biformeT. Das der Überstand von E. 
biformeT einen deutlichen Anstieg der IL-17 Expression hervor ruft ist sehr 
erstaunlich, weil dieses normale Darmbakterium weder die IL-8 Genexpression noch 
die IL-8 Konzentration in normalen und IL-1β vorbehandelten Caco-2 Zellen 
signifikant beeinflusst hat.  
In Bezug auf die CASP3 Genexpression induzierte nur der Überstand von L. 
acidophilus NCFM (0,05 ± 0,01; P< 0,0001) sowie die lyophilisierten Bakterien B. 
lactis Bt420 (0,63 ± 0,14; P< 0,01) und St. thermophilus ST21 (0,46 ± 0,01; P< 0,0001) 
einen deutlichen anti-apoptotischen Effekt, der eventuell auf Grund der Hemmung der 
IL-8 Genexpression zurück zuführen ist. 
Zusammenfassend kann man sagen, dass probiotische Bakterien wie L. acidophilus 
NCFM, B. lactis Bt420 und St. thermophilus ST21 einen präventiven Effekt auf die 
Entstehung von Entzündungen haben können. Einen generellen Rückschluss auf 
probiotisch eingestufte Bakterien kann man aber nicht ziehen, da sich in vielen Zell- 
und Tierversuchen gezeigt hat, dass Immunsystem fördernde Eigenschaften nicht nur 
spezies-, sonder auch stammspezifisch sind und auch die Dosis der Bakterien 
Ausschlag gebend ist. 
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 IL-8 ELISA  
without  IL-1β  
  mean 
standard 
deviation significant 
Control 1.00    
Butyrate 5 µM 1.07 0.22 P> 0.05 
Genistein 100 µM 0.53 0.05 P< 0.05 
Genistein 200 µM 0.44 0.06 P< 0.05 
Folic acid 200 µM 1.15 0.13 P> 0.05 
Zebularin 100 µM 2.13 0.49 P< 0.05 
Chrysin 50 µM 4.54 0.41 P< 0.0001 
EGCG 100µM 1.10 0.15 P> 0.05 
Annex 1: IL-8 ELISA of Caco-2 cells after stimulation with standards 
 
 
 
 IL-8 ELISA  
with IL-1β  
  mean 
standard 
deviation significant 
Control 1.00    
Butyrate 5 µM 0.90 0.04 P> 0.05 
Genistein 100 µM 0.66 0.13 P< 0.05 
Genistein 200 µM 0.48 0.03 P< 0.0001 
Folic acid 200 µM 0.66 0.04 P< 0.001 
Zebularin 100 µM 1.60 0.11 P< 0.001 
Chrysin 50 µM 0.91 0.03 P< 0.01 
EGCG 100µM 0.38 0.14 P< 0.001 
Annex 2: IL-8 ELISA of IL-1β pretreated Caco-2 cells after stimulation with standards 
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 IL-8 gene expression  IL-17 gene expression  
  mean 
standard 
deviation significant mean 
standard 
deviation significant 
Control 1.00    1.00    
Butyrate 1.38 0.37 P> 0.05 3.72 1.23   
Genistein 5.86 2.38 P< 0.01 7.08 2.48   
Zebularin 1.33 0.42 P> 0.05       
Folic acid 1.27 0.09 P< 0.01       
Chrysin 1.97 0.23 P< 0.001       
EGCG 1.31 0.13 P< 0.01       
Annex 3: gene expression of IL-8 and IL-17 in Caco-2 cells after standard treatment 
 
 
 CASP3 gene expression  
  mean 
standard 
deviation significant 
Control 1.00     
Butyrate 1.88 0.07 P< 0.01 
Genistein 1.74 0.03 P< 0.001 
Zebularin 2.04 0.12 P< 0.001 
Folic acid 0.88 0.12 P> 0.05 
Chrysin 1.09 0.12 P> 0.05 
EGCG 1.08 0.07 P> 0.05 
Annex 4: CASP3 gene expression in Caco-2 cells after standard treatment 
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 CPT1A gene expression  CPT1B gene expression  
  mean 
standard 
deviation significant mean 
standard 
deviation significant 
Control 1.00     1.00     
Butyrate 5.22 0.27 P< 0.001 0.66 0.02 P< 0.001 
Genistein 7.06 0.69 P< 0.01 1.33 0.27 P> 0.05 
Zebularin       1.40 0.19 P> 0.05 
Folic acid       1.00 0.01 P> 0.05 
Chrysin       0.99 0.15 P> 0.05 
EGCG       1.16 0.04 P< 0.05 
Annex 5: gene expression of CPT 1A and CPT 1B in Caco-2 cells after treatment with standards 
 
 
 CPT1A gene expression  
  mean 
standard 
deviation significant 
Control 1.00     
supernatant Lactobacillus acidophilus 
NCFM 0.37 0.04 P< 0.001 
supernatant Bifidobacterium animalis 
subsp. lactis 420 0.70 0.05 P< 0.05 
supernatant Streptococcus salivarius 
subsp. thermophilus ST21 0.52 0.05 P< 0.001 
supernatant Escherichia coli XL-blue 2.14 0.02 P< 0.01 
supernatant Eubacterium biformeT 1.36 0.10 P< 0.05 
Annex 6: CPT 1A gene expression in Caco-2 cells after treatment with bacterial supernatants 
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 CPT1B gene expression  
  mean 
standard 
deviation significant 
Control 1.00     
Lactobacillus acidophilus 
NCFM 0.71 0.09   
Bifidobacterium animalis subsp. 
lactis 420 0.44 0.03   
Streptococcus salivarius subsp. 
thermophilus ST21 0.86 0.09   
supernatant Lactobacillus 
acidophilus NCFM 0.94 0.04 P> 0.05 
supernatant Bifidobacterium 
animalis subsp. lactis 420 1.63 0.06 P< 0.01 
supernatant Streptococcus 
salivarius subsp. thermophilus 
ST21 0.50 0.02   
supernatant Escherichia coli XL-
blue 1.15 0.07 P> 0.05 
supernatant Eubacterium 
biformeT 0.82 0.04 P> 0.05 
Annex 7: CPT 1B gene expression in Caco-2 cells after treatment with bacteria and bacterial supernatant 
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 ERS1 gene expression  
  mean 
standard 
deviation significant 
Control 1.00     
supernatant Lactobacillus acidophilus 
NCFM 0.55 0.07 P> 0.05 
supernatant Bifidobacterium animalis 
subsp. lactis 420 1.32 0.12 P> 0.05 
supernatant Streptococcus salivarius 
subst. thermophilus ST21 0.39     
supernatant Eubacterium biformeT  0.72 0.10 P> 0.05 
supernatant Escherichia coli XL-blue 0.78 0.16 P> 0.05 
Annex 8: ESR1 gene expression in Caco-2 cells after stimulation with bacterial supernatant 
 
 
 ERS1 gene expression  
  mean 
standard 
deviation significant 
Control 1.00     
Butyrate 1.25 0.08 P> 0.05 
Genistein 3.76 0.61 P< 0.01 
Annex 9: ERS1 gene expression in Caco-2 cells after stimulation with standards 
 
 
 
 
 
 
 
 
 
 
 
86 ANNEX 
 
 DMNT3a gene expression HDAC2 gene expression  
  mean 
standard 
deviation significant mean 
standard 
deviation significant 
Control 1.00     1.00     
Butyrate 1.45 0.2 P> 0.05 1.09 0.12 P> 0.05 
Genistein 0.34 0.04 P< 0.001 1.44 0.05 P< 0.01 
Zebularin 1.40 0,05 P< 0.01 1.11 0.07 P> 0.05 
Folic acid 0.92 0.10 P> 0.05 0.96 0.02 P> 0.05 
Chrysin 0.95 0.07 P> 0.05 1.07 0.06 P> 0.05 
EGCG 0.93 0.14 P> 0.05 1.29 0.01 P< 0.001 
Annex 10:  gene expression of DNMT3a and HDAC2 in Caco-2 cells after stimulation with standards 
 
 
 DMNT 3a gene expression 
  mean 
standard 
deviation significant 
Control 1.00     
Lactobacillus acidophilus NCFM 0.75 0.07 P< 0.001 
Bifidobacterium animalis subsp. lactis 420 0.45 0.01 P< 0.0001 
Streptococcus salivarius subsp. 
thermophilus ST21 0.77 0.06 P< 0.01 
supernatant Lactobacillus acidophilus 
NCFM 0.79 0.04 P< 0.0001 
supernatant Bifidobacterium animalis 
subsp. lactis 420 0.59 0.07 P< 0.0001 
supernatant Streptococcus salivarius 
subst. thermophilus ST21 1.72 0.03 P< 0.0001 
supernatant Eubacterium biformeT 1.47 0.15 P< 0.0001 
supernatant Escherichia coli XL-blue 0.42 0.02 P< 0.0001 
Annex 11:  DNTM3a gene expression in Caco-2 cells after treatment with bacteria and bacterial supernatant 
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 HDAC2 gene expression  
  mean 
standard 
deviation significant 
Control 1.00     
Lactobacillus acidophilus NCFM 0.95 0.07 P> 0.05 
Bifidobacterium animalis subsp. lactis 420 0.61 0.01 P< 0.01 
Streptococcus salivarius subsp. 
thermophilus ST21 1.02 0.08 P> 0.05 
supernatant Lactobacillus acidophilus 
NCFM 0.44 0.01 P< 0.0001 
supernatant Bifidobacterium animalis 
subsp. lactis 420 0.67 0.05 P< 0.0001 
supernatant Streptococcus salivarius 
subst. thermophilus ST21 1.55 0.02 P< 0.0001 
supernatant Eubacterium biformeT 1.28 0.02 P< 0.001 
supernatant Escherichia coli XL-blue 0.86 0.05 P< 0.01 
Annex 12:  HDAC2 gene expression in Caco-2 cells after stimulation with bacteria and bacterial supernatant 
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8 PROTOCOLS 
8.1 Total RNA Isolation- User Manual NucleoSpin RNA II (Macherey-Nagel) 
Total RNA purification from cultured cells and tissue with NucleoSpin RNA II 
 
1. Homogenization of sample 
• Disrupt up to 30 mg of tissue (for sample amounts see section 2.3; for 
homogenization methods see section 2.4) 
• Up to 5 x 106 eukaryotic cultured cells are collected by centrifugation and 
lysed by addition of RA1 directly 
 
2. Cell lyses 
• Add 350 µl Buffer RA1 and 3.5 µl β-mercaptoethanol to the cell pellet or to 
ground tissue and vortex vigorously 
 
3. Filtration of the lysate 
• Reduce viscosity and clear the lysate by filtration through NucleoSpin 
Filter Columns (violet ring): Place NucleoSpin Filter Columns in a 
Collection Tube, apply the mixture, and centrifuge for 1 min at 11,00 x g. 
• In case of visible pellet formation (depending on sample amount and nature) 
transfer supernatant without any formed pellet to a new 1.5 ml 
microcentrifuge tube (not supplied) 
 
4. Adjust RNA binding conditions 
• Discard the NucleoSpin Filter Column and add 350 µl ethanol(70 %) to the 
homogenized lysate and mix by pipetting up and down (5 times). 
• Alternatively transfer flow-through into a new 1.5 ml microcentrifuge tube 
(not provided), add 350 µl ethanol(70 %), and mix by vortexing (2 x 5 sec). 
 
5. Bind RNA 
• For each preparation, take one NucleoSpin RNA II Column (light blue 
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ring) placed in a Collection Tube. Pipette lysate up and down 2-3 times and 
load the lysate to the column. Centrifuge for 30 sec at 11,000 x g. Place the 
column in a new Collection Tube (2 ml). 
 
6. Desalt silica membrane 
• Add 350 µl MDB (Membrane Desalting Buffer) and centrifuge at 11,000 x g 
for 1 min to dry the membrane. 
 
7. Digest DNA 
• Prepare DNase reaction mixture in a sterile 1.5 ml microcentrifuge tube (not 
provided): for each isolation, add 10 µl reconstituted rDNase (also see 
section 3) to 90 µl Reaction Buffer for rDNase. Miss by flicking the tube. 
• Apply 95 µl DNase reaction mixture directly onto the center of the silica 
membrane of the column. Incubate at room temperature for 15 min. 
 
8. Wash and Dry silica membrane 
1st wash 
• Add 200 µl Buffer RA2 to the NucleoSpin RNA II Column. Centrifuge for 
30 sec at 11,000 x g. Place the column into a new Collection Tube (2 ml). 
2nd wash 
• Add 600 µl Buffer RA3 to the NucleoSpin RNA II Column. Centrifuge for 
30 sec at 11,000 x g. Discard flow-through and place the column back into 
the Collection Tube. 
3rd wash 
• Add 250 µl Buffer RA3 to the NucleoSpin RNA II Column. Centrifuge for 
2 min at 11,000 x g to dry the membrane completely. Place the column into 
a nuclease-free Collection Tube (1.5 ml, supplied).  
 
9. Elute highly pure RNA 
• Elute the RNA in 60 µl RNase-free Water (supplied) and centrifuge at 
11,000 x g for 1 min. 
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10.1 Abstract for poster presentation 
10.1.1 NuGOweek 2009, Montecatini Terme, Aug. 31-Sep. 3 2009 
 
EPIGENETIC REGULATION OF IL-8 AND E-CADHERIN GENE 
EXPRESSION BY BUTYRATE, FOLIC ACID, AND GENISTEIN INCLUDES 
DNA-METHYLATION AND HISTONE ACETYLATION 
 
E. Aumueller, A. Gnauck, C. Berner, P. Klein, A. G. Haslberger  
Department of Nutrition, University of Vienna  
Alexander.haslberger@univie.ac.at  
 
The expression of IL-8 and E-Cadherin regulates the interactions between immune 
cells and epithelia in the GI-tract involving epigenetic mechanisms. Because of the 
epigenetic activities of the SCF butyrate, produced by intestinal microbiota, as well as 
genistein and folic acid we analyzed effects on histone acetylation and DNA-
methylation on the expression of IL-8 and E-Cadh.  
Gene expression was analyzed by real time PCR, DNA-methylation by Methylation 
Specific PCR (MSP), bisulfite sequencing PCR (BSP) and histone acetylation by 
Chromatin immunoprecipitation in the CACO-2 cell line model.  
IL-8 and E-Cadh expression was increased by genistein, butyrate, folic acid and the 
DNA methyltransferase inhibitor zebularine. Whereas zebularine decreased DNA 
methylation of E-Cadh and IL-8 (on the sites -1342 and -1412), butyrate enhanced the 
histone acetylation on H3 lysine 9 at IL-8. Genistein and butyrate also stimulated the 
apoptose relevant caspase3. Changes in butyrate producing GI-microbiota (Clostridium 
cluster IX and XIVa) were found due to nutrition.  
As the levels of genistein, folic acid, and butyrate in the GI-tract can be modulated by 
nutrition, nutritional concepts may be feasible to interfere with epigenetic mechanisms 
in inflammatory GI diseases. 
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10.1.2 Epigenetic World Congress, Berlin, Sep. 17-18 2009  
 
Food ingredients modulate epigenetic control of expression of estrogen receptor and 
tumor suppressor genes  
 
Aumueller E.1, Berner C.1, Gnauck A.1, Just A.2, Haslberger AG1  
1University of Vienna, Department for nutritional sciences  
2Medical University of Vienna, Department of Obestrics and Gynecology  
 
Estrogen receptor alpha (ESR1) plays vital roles in the development and progression 
of breast cancer and metabolic disorders. The expression is known to be regulated by 
epigenetic mechanisms. Also the tumor suppressor genes P15 and P16 are aberrantly 
methylated in several cancer types.  
 
To evaluate possible effects of dietary compounds on the epigenetic gene expression 
Caco2-cells were treated with butyrate, resveratrol, genistein, zebularine, folic acid, 
chrysin, and EGCG, which are known to have estrogenic or epigenetic effects. Gene 
expression was analyzed for ESR1, P15, and P16 by quantitative real-time-PCR. 
Methylation of specific CpG-sites was determined by methylation-specific PCR.  
 
Treatment with genistein, folate, EGCG, and resveratrol increased and zebularine and 
chrysin decreased methylation of ESR1. P15 methylation was enhanced by genistein 
and folate and decreased by chrysin, zebularine, butyrate, EGCG, and resveratrol. 
Treatment with folate resulted in P16 hypermethylation whereas all other agents 
resulted in hypomethylation of this gene. Changes in methylation corresponded with 
altered gene expression. In contrast to CACO cells human blood cells show less 
methylation on the investigated genes. These results suggest that food ingredients 
may influence epigenetic modification of cancer relevant gene expression and might be 
considered for supplemental treatment and prevention. 
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10.1.3 19th International Congress of Nutrition, Bangkok, Oct. 4-9 2009  
 
REGULATION OF IL-8 AND IL-17 EXPRESSION BY BUTYRATE, FOLIC 
ACID, AND GENISTEIN INCLUDES DNA METHYLATIONAND HISTONE 
ACETYLATION  
E. Aumueller, C. Berner, A. Gauck, P. Klein, A. G. Haslberger  
Department of Nutrition, University of Vienna  
 
IL-8 and IL-17 regulate interactions between immune cells and epithelia in the GI-
tract, involving epigenetic mechanisms. Because of the epigenetic activities of the SCF 
(short chain fatty acid) butyrate, produced by intestinal microbiota, genistein and folic 
acid we analyzed effects on histone acetylation and DNA-methylation on interleukin-8 
and -17 genes.  
 
We analyzed gene expression by real time PCR, DNA-methylation by bisulfite 
sequencing PCR, and histone acetylation by Chromatin immunoprecipitation in the 
CACO-2 cell line model.  
 
IL-8 and IL-17 expression was increased by genistein, butyrate, and folic acid. Folic 
acid stimulated the IL-8-DNA-methylation on the sites -1342 and -1412. Butyrate 
stimulated the histone acetylation on H3 lysine 9 at IL-8. Genistein and butyrate also 
stimulated apoptosis relevant caspase-3. Changes in butyrate producing GI-
microbiota (Clostridium cluster IX and XIVa) were found due to nutrition.  
 
As the levels of genistein, folic acid, and butyrate in the GI-tract can be influenced by 
nutrition, nutritional concepts may be feasible to interfere with IL-8 and IL-17 
expression in inflammatory GI diseases. 
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